Cirrhosis of liver, NAS

CHIRHEP_NAS

Cirrhosis of liver is when scar tissue replaces healthy liver tissue

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K74.6 Cause of death: ICD-10 — K74.6 2 out of 7 registries used, show all original rules.	2369
4. Check minimum number of events None	2369
5. Include endpoints None	2369
6. Filter based on genotype QC (FinnGen only)	2142

Control definitions (FinnGen only)

Control exclude: CIRRHOSIS_BROAD

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K74
Name in latin: Cirrhosis hepatis alia sive non specificata

NAME	CHIRHEP_NAS
CONTROL_EXCLUDE	CIRRHOSIS_BROAD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K746
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K746
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cirrhosis of liver, NAS based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	15092	5951	8918
Only index persons	11422	4569	6853
Unadjusted period prevalence (%)
Whole population	0.22	0.17	0.25
Only index persons	0.22	0.17	0.26
Median age at first event (years)
Whole population	66.47	68.55	65.01
Only index persons	66.10	67.59	65.10

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2142	834	1308
Unadjusted period prevalence (%)	0.48	0.30	0.60
Median age at first event (years)	67.56	67.02	67.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2195: Matched controls
21950

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z94.4

ICD-10 Finland

Liver transplant status

140.8

313.6

157

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

32.9

309.2

201

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

82.3

307.7

293

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

8064.9

307.7

604

R18

ICD-10 Finland

Ascites

70.5

307.7

653

131

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

23.0

307.7

383

200

A06AD11

ATC

lactulose; oral

6.1

307.7

867

2134

C03DA01

ATC

spironolactone; oral

15.6

307.7

1268

1765

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

+∞

307.7

585

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

15.6

307.7

327

243

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

7.1

307.7

865

1840

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

36.0

307.7

206

C03CA01

ATC

furosemide; systemic

7.1

307.7

1516

5269

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

9.2

307.7

1576

4775

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4503599627370496.0

307.7

2194

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.4

307.7

808

1167

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

41.4

307.7

426

127

C07AG02

ATC

carvedilol; oral

7.6

292.3

476

773

K72.9

ICD-10 Finland

Hepatic failure, unspecified

67.0

273.5

150

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

55.0

253.2

144

103

Kela drug reimbursment

Diabetes, insulin-treated

4.3

252.2

1186

4691

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

535.5

245.6

240

A10AE04

ATC

insulin glargine; parenteral

5.4

241.8

582

1365

A05AA02

ATC

ursodeoxycholic acid; oral

23.0

241.1

178

K76.9

ICD-10 Finland

Liver disease, unspecified

21.8

239.8

181

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.1

233.4

1093

4257

K92.0

ICD-10 Finland

Haematemesis

11.7

216.1

231

218

D97

ICPC

Liver disease NOS

46.0

213.4

126

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

+∞

205.5

194

B18.2

ICD-10 Finland

Chronic viral hepatitis C

27.9

203.7

139

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.8

200.2

1040

4248

A10AB05

ATC

insulin aspart; parenteral

5.4

193.7

441

973

D64.9

ICD-10 Finland

Anaemia, unspecified

4.5

190.4

586

1652

127

Kela drug reimbursment

Transplant complication

14.8

186.0

170

124

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

46.8

182.0

107

A10BA02

ATC

metformin; oral

3.5

180.1

1118

5035

T90

ICPC

Diabetes non-insulin dependent

3.5

174.2

1009

4333

A07AA11

ATC

rifaximin; oral

215.1

173.8

178

A10BH01

ATC

sitagliptin; oral

4.5

173.2

514

1401

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.2

172.2

584

1758

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.9

164.8

423

1025

K92.1

ICD-10 Finland

Melaena

5.6

159.8

336

685

K74.3

ICD-10 Finland

Primary biliary cirrhosis

33.0

152.2

L04AA06

ATC

mycophenolic acid; systemic

10.9

151.5

168

166

L04AD02

ATC

tacrolimus; systemic

17.6

151.3

125

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

10.2

150.1

174

183

JJC00

NOMESCO Finland

Allogenic transplantation of liver

510.8

146.3

144

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

8.8

144.5

188

230

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

7.3

143.2

221

330

C07AA05

ATC

propranolol; systemic

3.5

142.8

665

2445

JN3AD

NOMESCO Finland

Abdominal CT examination

3.7

142.6

576

1933

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

11.5

141.2

150

139

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.8

137.7

345

814

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

40.9

130.2

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

9.0

128.7

164

195

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

116.7

690

2878

I81

ICD-10 Finland

Portal vein thrombosis

30.2

114.9

K70.4

ICD-10 Finland

Alcoholic hepatic failure

+∞

112.5

107

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.5

112.4

300

740

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.1

111.5

254

550

A10AC01

ATC

insulin (human); parenteral

4.2

110.3

331

892

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

49.9

108.6

K70.0

ICD-10 Finland

Alcoholic fatty liver

53.1

108.3

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.3

107.5

304

783

K72.1

ICD-10 Finland

Chronic hepatic failure

192.9

106.4

110

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

103.5

562

2215

G93.4

ICD-10 Finland

Encephalopathy, unspecified

59.5

103.5

K76.7

ICD-10 Finland

Hepatorenal syndrome

1046.0

103.1

100

TK800

NOMESCO Finland

Hemodialysis

7.4

101.2

152

219

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

267.4

100.6

102

A10AE05

ATC

insulin detemir; parenteral

4.6

100.0

256

609

A10BB12

ATC

glimepiride; oral

3.9

98.0

323

928

198

Kela drug reimbursment

Sorafenib

38.5

97.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

97.2

689

3122

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.3

96.2

277

721

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

9.6

95.5

114

124

WW500

NOMESCO Finland

Blood transfusion

5.1

95.3

214

456

Z51.5

ICD-10 Finland

Palliative care

3.4

93.7

399

1355

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.1

93.5

289

792

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.8

92.9

597

2563

K74.0

ICD-10 Finland

Hepatic fibrosis

936.7

92.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.3

92.4

198

405

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

91.8

1408

9104

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.0

90.6

142

214

160

Kela drug reimbursment

exenatide

7.2

90.5

139

205

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

9.1

89.8

112

129

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.4

89.5

186

370

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

20.6

89.1

A46

ICD-10 Finland

Erysipelas

2.8

87.8

549

2315

UJF32

NOMESCO Finland

Coloscopy

2.5

86.6

835

4348

K29.6

ICD-10 Finland

Other gastritis

10.2

83.3

E66.00

ICD-10 Finland

Metabolic syndrome

4.1

82.7

250

672

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

11.9

82.1

K70.1

ICD-10 Finland

Alcoholic hepatitis

828.4

82.0

N02AX02

ATC

tramadol; systemic, rectal

2.3

81.2

1214

7600

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

20.2

79.3

TJA10

NOMESCO Finland

Laparocentesis

28.6

78.7

JN4AD

NOMESCO Finland

Body CT examination

2.9

78.5

460

1863

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

76.5

434

1726

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

76.1

410

1585

SPAT1262

SPAT

Handing over of treatment supplies

2.6

76.1

581

2687

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

73.7

698

3557

A41.9

ICD-10 Finland

Sepsis, unspecified

4.7

73.3

181

416

I50.0

ICD-10 Finland

Congestive heart failure

3.3

73.1

307

1025

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

24.2

72.8

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

157.4

72.5

L04AD01

ATC

ciclosporin; systemic

7.3

69.8

104

148

K29.7

ICD-10 Finland

Gastritis, unspecified

4.7

68.6

168

383

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.8

68.5

128

230

E87.5

ICD-10 Finland

Hyperkalaemia

6.3

68.4

118

196

A02BC02

ATC

pantoprazole; systemic

2.5

68.2

1708

12856

K83.0

ICD-10 Finland

Cholangitis

7.1

64.7

145

A10BH05

ATC

linagliptin; oral

3.6

63.4

230

698

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.8

60.5

336

1310

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

60.4

406

1746

205

Kela drug reimbursment

Chronic hypertension

2.1

59.5

808

4699

A10BJ02

ATC

liraglutide; parenteral

5.0

59.4

133

281

M04AA01

ATC

allopurinol; systemic

2.4

57.9

467

2185

A10BX07

ATC

[U] liraglutide

7.3

57.8

122

UJF30

NOMESCO Finland

Ileoscopy through colon

2.7

56.3

348

1431

177

Kela drug reimbursment

Insulin glargine 300 U / ml

6.1

56.1

168

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.2

55.8

247

846

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.8

55.5

177

491

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

288.7

55.5

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.5

55.4

141

331

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.1

55.3

256

900

162

Kela drug reimbursment

liraglutide

7.6

55.3

107

A10BJ06

ATC

semaglutide; parenteral

3.4

55.3

213

670

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

4.8

54.4

126

274

K76.6

ICD-10 Finland

Portal hypertension

+∞

53.3

R4110

NOMESCO Finland

Physiotherapy

2.1

52.8

757

4451

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

6.1

52.6

158

WX892

NOMESCO Finland

Monitored bed care

2.9

52.1

276

1045

A10BG03

ATC

pioglitazone; oral

4.6

51.8

127

289

P15

ICPC

Chronic alcohol abuse

4.6

51.4

127

291

A10BD07

ATC

metformin and sitagliptin; systemic

3.6

50.9

181

540

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.4

50.8

140

K65.0

ICD-10 Finland

Acute peritonitis

8.4

50.2

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

6.1

50.1

152

J01MA02

ATC

ciprofloxacin; systemic

2.0

50.0

1017

6728

N17.8

ICD-10 Finland

Other acute renal failure

6.6

50.0

126

JN4CD

NOMESCO Finland

Very extensive body CT

3.8

50.0

159

440

R50.9

ICD-10 Finland

Fever, unspecified

2.3

49.9

445

2162

XW000

NOMESCO Finland

Bone marrow biopsy

3.6

49.4

175

521

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.8

49.2

159

445

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

20.9

48.8

JJ5AT, ,

NOMESCO Finland

477.9

47.5

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.0

46.4

135

350

N19

ICD-10 Finland

Unspecified kidney failure

3.5

45.5

163

488

A10BX04

ATC

[U] exenatide

7.2

45.4

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.6

45.4

154

445

N02AA05

ATC

oxycodone; systemic

2.1

44.8

564

3130

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

44.7

170

529

A10BK03

ATC

empagliflozin; oral

2.4

44.6

360

1669

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

44.4

563

3130

A28

ICPC

Limited function/disability NOS

2.1

44.2

532

2900

A10BK01

ATC

dapagliflozin; oral

2.6

44.1

278

1147

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.7

43.7

142

398

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.4

43.7

113

268

ZX120

NOMESCO Finland

Intravenous

2.6

42.8

288

1226

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

42.7

844

5452

JJA20

NOMESCO Finland

Open biopsy of liver

16.6

42.7

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.3

42.6

112

269

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.8

42.5

208

E66.01

ICD-10 Finland

Obesity due to excess calories

2.7

41.8

242

956

E66.9

ICD-10 Finland

Obesity, unspecified

4.1

41.7

119

304

R60.0

ICD-10 Finland

Localized oedema

2.3

41.7

375

1817

L04AX01

ATC

azathioprine; systemic

3.6

41.5

143

417

S97

ICPC

Chronic ulcer skin

2.8

41.1

229

887

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.2

40.7

169

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

40.5

456

2416

R04.0

ICD-10 Finland

Epistaxis

2.6

39.9

253

1045

WVA20

NOMESCO Finland

Medicine administration

4.0

39.6

116

302

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

39.2

391

1974

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

39.1

707

4412

E66.8

ICD-10 Finland

Other obesity

3.3

39.0

153

485

I86.4

ICD-10 Finland

Gastric varices

383.9

38.1

A41.8

ICD-10 Finland

Other specified sepsis

4.6

38.0

203

F10.24

ICD-10 Finland

Alcohol depence active use

5.6

37.9

131

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.4

37.9

144

447

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

37.8

804

5267

J01FF01

ATC

clindamycin; systemic

1.9

37.6

681

4241

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.4

37.5

226

UJF92

NOMESCO Finland

Capsular endoscopy

4.8

37.3

186

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.9

37.2

116

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

83.6

36.9

D64.8

ICD-10 Finland

Other specified anaemias

4.7

36.1

187

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

36.1

338

1659

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

5.1

36.0

156

WX872

NOMESCO Finland

Intensive care

2.8

36.0

187

697

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.9

35.8

Z2446

NOMESCO Finland

Social worker

2.8

35.7

188

705

C07AB07

ATC

bisoprolol; oral

1.8

35.7

1246

9379

Z3231

NOMESCO Finland

Registered nurse

1.8

34.5

667

4218

AA1AD

NOMESCO Finland

CT of head and brain

1.8

34.4

771

5098

R06.0

ICD-10 Finland

Dyspnoea

1.8

34.3

706

4550

I50

ICD-10 Finland

Heart failure

3.6

34.2

114

325

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

77.4

33.9

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.3

33.9

130

406

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

33.5

405

2189

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.2

33.2

136

442

WX002

NOMESCO Finland

Sedation and analgesia

1.9

33.2

501

2923

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.6

33.2

214

889

UJD02

NOMESCO Finland

Gastroscopy

2.9

33.2

160

572

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

33.0

188

734

K75.4

ICD-10 Finland

Autoimmune hepatitis

45.2

32.8

A10BJ05

ATC

dulaglutide; parenteral

4.4

32.7

198

ZX108

NOMESCO Finland

Inhalation

7.7

32.7

R60.9

ICD-10 Finland

Oedema, unspecified

2.7

32.7

180

691

ZXD05

NOMESCO Finland

Urgent procedure

1.8

32.7

691

4478

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.9

32.6

158

566

A10AD05

ATC

insulin aspart; parenteral

4.5

32.4

179

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

32.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

32.3

429

2395

A08

ICPC

Swelling

2.7

32.2

187

738

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

32.2

328

1661

R41.0

ICD-10 Finland

Disorientation, unspecified

3.5

31.9

115

345

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

53.7

31.3

D05AX52

ATC

calcipotriol, combinations; topical

2.8

31.2

163

608

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

7.8

31.1

H02AB06

ATC

prednisolone; systemic

1.7

31.0

1099

8184

M10.9

ICD-10 Finland

Gout, unspecified

2.4

30.9

241

1091

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

42.9

30.9

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

30.8

648

4180

J01MA12

ATC

levofloxacin; systemic

1.9

30.7

492

2919

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

6.7

30.7

B82

ICPC

Anaemia other/unspecified

3.4

30.7

113

344

C10AC01

ATC

colestyramine; oral

4.0

30.6

235

E66.0

ICD-10 Finland

Obesity due to excess calories

6.3

30.1

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.5

29.9

203

863

B80

ICPC

Iron deficiency anaemia

3.9

29.9

230

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.2

29.8

287

1418

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.9

29.8

235

L28

ICPC

Limited function/disability (L)

1.9

29.7

500

3009

E87.6

ICD-10 Finland

Hypokalaemia

3.2

29.5

123

404

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.2

29.4

117

374

H02AB04

ATC

methylprednisolone; systemic

2.0

29.3

352

1891

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

29.1

617

3976

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

32.2

29.1

SPAT1088

SPAT

Blood transfusion

9.6

28.9

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.5

28.8

158

Z2221

NOMESCO Finland

Medical doctor

1.8

28.7

605

3890

JN4BD

NOMESCO Finland

Extensive body CT

2.1

28.5

295

1499

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

49.3

28.4

N05CF01

ATC

zopiclone; oral

1.7

28.2

750

5141

R94.5

ICD-10 Finland

Abnormal results of liver function studies

5.7

27.9

E83.1

ICD-10 Finland

Disorders of iron metabolism

8.5

27.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

27.9

181

753

N05CD07

ATC

temazepam; oral

2.1

27.8

311

1625

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

27.8

261

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

27.7

266

1311

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

7.6

27.6

JAH01

NOMESCO Finland

Laparoscopy

3.1

27.4

115

379

JCA20

NOMESCO Finland

Ligature of oesophageal varices

+∞

27.1

K55.8

ICD-10 Finland

Other vascular disorders of intestine

9.5

27.1

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.1

26.7

112

369

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

26.7

128

456

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

26.3

198

881

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

8.8

26.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

26.2

192

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.3

26.2

UJK02

NOMESCO Finland

ERCP

3.4

26.1

282

I85

ICD-10 Finland

Oesophageal varices

+∞

26.1

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.8

26.0

126

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

5.9

25.8

A10BH02

ATC

vildagliptin; oral

3.9

25.7

204

A10BB01

ATC

glibenclamide; oral

2.9

25.6

122

433

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

25.5

108

358

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

25.5

1498

12402

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

7.4

25.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

25.4

153

614

C01AA05

ATC

digoxin; systemic

2.2

25.3

225

1074

L01XE05

ATC

[U] sorafenib

36.1

25.2

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.8

25.1

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

25.0

252

1264

R02

ICPC

Shortness of breath/dyspnoea

1.9

25.0

354

2005

RS220, ,

NOMESCO Finland

5.4

25.0

N05BA04

ATC

oxazepam; oral

1.7

24.9

574

3761

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

24.7

302

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.9

24.7

196

R60.1

ICD-10 Finland

Generalized oedema

7.3

24.6

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

5.3

24.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

24.6

361

2068

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.5

24.4

160

668

UJD10, ,

SPAT

3.4

24.3

260

K55.2

ICD-10 Finland

Angiodysplasia of colon

7.7

24.2

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

24.0

576

3811

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

23.0

23.9

323

Kela drug reimbursment

Sorafenib

31.4

23.7

B01AA03

ATC

warfarin; systemic

1.7

23.7

494

3143

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.4

23.6

265

K76.89

ICD-10 Finland

Other specified diseases of liver

21.6

23.4

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

4.5

23.4

133

V03AE01

ATC

polystyrene sulfonate; oral

4.5

23.4

129

P19

ICPC

Drug abuse

8.9

23.3

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.4

23.2

168

734

K83.1

ICD-10 Finland

Obstruction of bile duct

4.4

23.0

135

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

23.0

728

5156

K74

ICD-10 Finland

Fibrosis and cirrhosis of liver

+∞

23.0

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

5.1

22.8

N07BB01

ATC

disulfiram; oral

2.8

22.7

118

439

SPAT1254

SPAT

Administration of medicine

1.9

22.6

346

2005

Z3226

NOMESCO Finland

Physiotherapist

1.8

22.6

422

2598

K77

ICPC

Heart failure

3.5

22.6

228

SPAT1255

SPAT

Intravenous administration of medicine

2.3

22.5

188

874

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

7.0

22.5

ZXE00

NOMESCO Finland

One hour or less

1.6

22.3

823

6035

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

22.2

128

502

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

22.2

883

6585

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

22.1

811

5935

D25

ICPC

Abdominal distension

3.8

22.0

184

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

5.3

21.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

21.7

131

526

C09AA02

ATC

enalapril; systemic

1.7

21.7

488

3161

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.0

21.6

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

21.6

196

942

J01DB01

ATC

cefalexin; oral

1.7

21.6

1777

15621

J94.8

ICD-10 Finland

Other specified pleural conditions

3.9

21.6

164

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

21.6

326

1880

E000001, ,

ATC

1.8

21.5

405

2495

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.8

21.3

102

K07

ICPC

Swollen ankles/oedema

2.5

21.3

144

610

UJF02

NOMESCO Finland

Peroral enteroscopy

7.0

21.2

A10AB06

ATC

insulin glulisine; parenteral

5.0

21.2

E0000UV, ,

ATC

1.6

21.1

860

6427

B01AB05

ATC

enoxaparin; parenteral

1.6

20.9

725

5220

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

5.1

20.9

K74.2

ICD-10 Finland

Hepatic fibrosis with hepatic sclerosis

+∞

20.9

A10BJ01

ATC

exenatide; parenteral

4.8

20.8

100

A12BA01

ATC

potassium chloride; oral

2.6

20.8

119

465

L01EX02

ATC

sorafenib; oral

37.6

20.8

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

211.9

20.6

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.7

20.6

101

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

20.6

255

1376

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.2

20.5

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

20.5

184

881

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

5.4

20.4

D07AC01

ATC

betamethasone; topical

1.6

20.3

791

5842

D73.1

ICD-10 Finland

Hypersplenism

32.9

20.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

20.0

309

358

Kela drug reimbursment

liraglutide

6.6

20.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

19.8

628

4417

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

36.1

19.8

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.0

19.8

147

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.0

19.7

3A422, ,

NOMESCO Finland

74.2

19.7

H3600, E113,

ICD-10 Finland

4.3

19.6

122

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.3

19.5

118

A10AE06

ATC

insulin degludec; parenteral

2.8

19.5

358

A10AB04

ATC

insulin lispro; parenteral

3.1

19.5

271

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

19.3

161

747

TK810

NOMESCO Finland

Hemofiltration

6.4

19.3

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

5.9

19.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

19.2

345

2093

WX882

NOMESCO Finland

High dependency care

2.9

19.1

312

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

7.0

19.1

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.2

19.0

234

3019

Kela drug reimbursment

Lenvatinib

34.6

18.9

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.8

18.9

152

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

18.8

235

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.0

18.7

135

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

70.5

18.7

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

5.6

18.7

1508

Kela drug reimbursment

Lenvatinib

38.7

18.6

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.4

18.5

129

554

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.1

18.5

123

T74.1

ICD-10 Finland

Physical abuse

4.6

18.5

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

18.5

182

903

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.5

18.3

179

L01EX08

ATC

lenvatinib; oral

44.4

18.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

18.2

234

1276

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.8

18.1

152

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

18.1

155

728

A07EA06

ATC

budesonide; oral, local oral

2.7

18.0

356

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.8

18.0

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

18.0

355

2207

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.7

18.0

162

R53

ICD-10 Finland

Malaise and fatigue

1.6

18.0

518

3550

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.9

17.9

301

WW200, ,

SPAT

0.6

17.8

329

5099

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.1

17.8

118

C02EA02, ,

ATC

2.5

17.7

117

491

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.3

17.5

199

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.7

17.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

17.5

384

2457

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

17.4

241

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

17.4

163

793

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

5.0

17.4

R4190

NOMESCO Finland

Nutritional therapy

2.6

17.4

105

422

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

17.4

311

1881

R11

ICD-10 Finland

Nausea and vomiting

2.0

17.3

194

1009

S76

ICPC

Skin infection other

2.2

17.3

146

681

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

42.3

17.3

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.8

17.3

330

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.6

17.2

104

418

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.5

17.2

219

3769

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

14.9

17.1

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.6

17.1

101

401

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.1

17.1

233

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.8

17.0

140

K65.9

ICD-10 Finland

Peritonitis, unspecified

16.1

17.0

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

19.4

16.9

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.2

16.8

106

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.0

16.8

252

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

6.3

16.7

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.1

16.7

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

15.2

16.7

N06AX11

ATC

mirtazapine; oral

1.5

16.6

702

5225

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

7.3

16.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

16.5

498

3442

T89

ICPC

Diabetes insulin dependent

2.6

16.5

100

403

PC2SC

NOMESCO Finland

Liver angiography with X-ray

40.4

16.3

I50.1

ICD-10 Finland

Left ventricular failure

2.2

16.2

141

666

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

16.2

148

713

K08.3

ICD-10 Finland

Retained dental root

1.9

16.1

200

1077

D07XC01

ATC

betamethasone; topical

1.8

16.1

280

1678

E87.2

ICD-10 Finland

Acidosis

6.0

16.1

E86

ICD-10 Finland

Volume depletion

2.9

16.0

275

3AC01, ,

NOMESCO Finland

4.9

15.9

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

4.9

15.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

15.9

173

890

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

5.4

15.9

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.1

15.9

106

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

15.8

185

976

L04AA01

ATC

[U] ciclosporin

4.3

15.7

A07AA09

ATC

vancomycin; oral

3.7

15.7

134

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.7

15.7

312

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

4.7

15.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

15.6

395

D50

ICD-10 Finland

Iron deficiency anaemia

3.3

15.6

178

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

26.5

15.6

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

15.6

464

3192

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

15.6

256

1508

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.0

15.6

225

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

19.4

15.5

WX402

NOMESCO Finland

General anaesthesia

1.6

15.5

478

3314

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

15.5

137

652

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

15.4

306

1901

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

14.9

15.4

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

15.3

363

2362

D05AX02

ATC

calcipotriol; topical

2.5

15.3

411

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

4.9

15.2

WZC30

NOMESCO Finland

Teaching

1.6

15.2

393

2615

D07AD01

ATC

clobetasol; topical

1.6

15.1

351

2271

F05.9

ICD-10 Finland

Delirium, unspecified

2.9

15.1

240

K76.1

ICD-10 Finland

Chronic passive congestion of liver

45.3

15.1

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

15.0

110

483

SPAT1265

SPAT

Breathalyser

4.8

15.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

14.9

138

668

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.6

14.9

139

N05AH04

ATC

quetiapine; oral

1.7

14.9

337

2168

D02AE01

ATC

carbamide; topical

2.1

14.8

143

704

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.8

14.8

121

WX419

NOMESCO Finland

Other general anesthesy

4.9

14.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

14.7

316

2003

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.1

14.7

135

652

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

14.6

284

1754

JA3GT

NOMESCO Finland

Insertion of tunnelled ascites drain

80.7

14.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

14.5

557

4044

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.8

14.5

M01AB01

ATC

indometacin; systemic, rectal

1.9

14.5

199

1109

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

36.3

14.4

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

14.3

100

430

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

6.0

14.3

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

14.3

395

2665

A10BG02

ATC

rosiglitazone; oral

3.4

14.3

153

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

14.3

255

1538

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

22.4

14.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

14.2

115

528

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

14.2

783

6097

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.4

14.2

420

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.0

14.2

102

Z72.1

ICD-10 Finland

Alcohol use

3.8

14.2

111

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.9

14.1

222

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

14.0

330

2141

D69.5

ICD-10 Finland

Secondary thrombocytopenia

10.9

14.0

A10AD01

ATC

insulin (human); parenteral

3.6

14.0

126

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

10.1

14.0

Z72.2

ICD-10 Finland

Drug use

15.9

13.9

A02BC01

ATC

omeprazole; systemic

1.5

13.8

565

4147

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

23.9

13.8

OAB43, ,

SPAT

0.5

13.7

135

2537

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.5

13.7

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.6

13.6

300

SPAT1229

SPAT

Assessment of need for aid

1.9

13.6

181

998

H3601, E113,

ICD-10 Finland

3.2

13.6

163

WX213

NOMESCO Finland

Lower leg blockade

4.6

13.5

C03AA03

ATC

hydrochlorothiazide; oral

1.8

13.5

217

1268

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

13.5

184

1022

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

13.5

102

455

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

140.8

13.5

A04

ICPC

Weakness/tiredness general

1.6

13.5

324

2113

C09AA05

ATC

ramipril; oral

1.5

13.4

602

4498

JAH00

NOMESCO Finland

Laparotomy

2.6

13.3

315

N05BA01

ATC

diazepam; systemic, rectal

1.7

13.3

273

1708

3A064, ,

NOMESCO Finland

9.7

13.2

K02.2

ICD-10 Finland

Caries of cementum

2.1

13.1

125

612

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

13.1

132

660

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.8

13.1

N06AB04

ATC

citalopram; systemic

1.5

13.1

407

2818

C07AB02

ATC

metoprolol; systemic

1.5

13.0

447

3160

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.5

13.0

319

K70

ICD-10 Finland

Alcoholic liver disease

50.3

12.8

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.4

12.8

395

WPA13

NOMESCO Finland

Palliative consultation

5.8

12.7

P16

ICPC

Acute alcohol abuse

3.4

12.6

130

A10BX02

ATC

repaglinide; oral

3.4

12.6

130

474, ,

NOMESCO Finland

70.3

12.6

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

12.6

259

RS221, ,

NOMESCO Finland

3.6

12.6

116

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

12.6

187

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

12.5

125

623

N03AX16

ATC

[U] pregabalin

1.5

12.5

484

3503

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.3

12.4

394

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

5.7

12.4

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.0

12.4

H02AB07

ATC

prednisone; oral

1.6

12.4

283

1820

130

Kela drug reimbursment

Malignant tumour

1.7

12.4

227

1378

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

12.3

133

682

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

12.3

128

648

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

5.4

12.3

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

3.8

12.3

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

12.3

454

J01DA01

ATC

[U] cefalexin

1.4

12.3

1230

10523

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.2

12.3

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

10.6

12.2

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

37.8

12.2

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.3

12.2

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.3

12.2

143

R03AC02

ATC

salbutamol; inhalant

1.4

12.2

1068

8936

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

12.2

252

1580

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.9

12.2

207

L40.8

ICD-10 Finland

Other psoriasis

4.6

12.1

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.7

12.1

100

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

12.5

12.1

K29.2

ICD-10 Finland

Alcoholic gastritis

12.5

12.1

ZZA00

NOMESCO Finland

Split skin graft

2.5

12.1

306

OAA67, ,

SPAT

0.4

12.1

1460

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.7

12.0

248

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

12.0

219

1328

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

11.9

224

1368

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.7

11.8

102

S18

ICPC

Laceration/cut

1.4

11.8

1039

8685

L40

ICD-10 Finland

Psoriasis

3.0

11.7

178

A11CC03

ATC

alfacalcidol; systemic

2.6

11.7

251

A10BB07

ATC

glipizide; oral

3.6

11.7

107

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

11.6

737

5831

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

11.6

270

K65.8

ICD-10 Finland

Other peritonitis

11.1

11.5

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.2

11.5

138

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.4

11.5

338

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

11.5

548

4123

UJK12

NOMESCO Finland

Peroral cholangioscopy

13.7

11.4

A10BD03

ATC

metformin and rosiglitazone; systemic

3.0

11.4

170

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

11.4

333

D05BB02

ATC

acitretin; oral

2.6

11.4

249

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

5.4

11.3

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

11.3

171

980

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

11.3

182

1063

N05BA12

ATC

alprazolam; oral

1.7

11.3

199

1193

SPAT1216

SPAT

Assessment of functional ability

1.5

11.3

337

2305

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

11.3

564

4276

D07AA02

ATC

hydrocortisone; topical

1.6

11.3

248

1578

K75.8

ICD-10 Finland

Other specified inflammatory liver diseases

35.2

11.3

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.7

11.2

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

4.9

11.2

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

5.6

11.2

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.1

11.1

101

486

JKA20

NOMESCO Finland

Cholecystectomy

2.5

11.1

282

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

8.1

11.1

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

11.2

11.0

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

11.0

104

508

R03BB04

ATC

tiotropium bromide; inhalant

1.6

11.0

238

1508

L17

ICPC

Foot/toe symptom/complaint

1.4

11.0

628

4872

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

13.9

11.0

K51.5

ICD-10 Finland

Left sided colitis

2.6

11.0

254

R77.0

ICD-10 Finland

Abnormality of albumin

43.5

10.9

K86.2

ICD-10 Finland

Cyst of pancreas

3.6

10.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

10.9

373

2627

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.1

10.9

SPAT1263

SPAT

Sampling

1.4

10.9

801

6479

WPB10

NOMESCO Finland

Making a convalescent care decision

5.4

10.9

N05AA02

ATC

levomepromazine; systemic

2.2

10.8

412

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.7

10.8

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

10.8

161

921

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

17.9

10.7

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

10.7

133

717

N06AA12

ATC

doxepin; systemic

2.0

10.7

113

576

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

10.7

467

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.1

10.7

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.1

10.7

K80.8

ICD-10 Finland

Other cholelithiasis

2.9

10.7

166

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

21.6

10.7

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

10.6

283

1885

R06AE07

ATC

cetirizine; oral

1.4

10.6

782

6319

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

10.6

258

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

10.6

442

RD210, ,

NOMESCO Finland

3.0

10.6

151

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.6

10.6

241

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

10.5

102

504

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

14.3

10.5

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.7

10.5

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.1

10.4

A07EC02

ATC

mesalazine; oral, rectal

2.0

10.4

110

561

A98

ICPC

Health maint/preventive medicine

0.7

10.4

1862

19639

207

Kela drug reimbursment

Chronic arrhythmias

1.5

10.4

383

2736

K81.9

ICD-10 Finland

Cholecystitis, unspecified

3.9

10.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

10.4

578

4459

B17.1

ICD-10 Finland

Acute hepatitis C

32.7

10.3

D77

ICPC

Malignant digestive neopl other/NOS

5.2

10.3

B01AB04

ATC

dalteparin; parenteral

2.0

10.3

111

570

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.7

10.3

192

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

10.6

10.3

RS120, ,

NOMESCO Finland

9.6

10.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

10.2

112

578

N06AX03

ATC

mianserin; oral

2.0

10.2

105

530

WX730

NOMESCO Finland

Conventional respirator

3.1

10.2

138

EBA00

NOMESCO Finland

Extraction of tooth

1.4

10.2

731

5875

T31

ICPC

Metabolic, Medical examin/health eval partial

4.1

10.2

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.7

10.1

C09BA02

ATC

enalapril and diuretics; systemic

1.7

10.1

186

1128

C10AA07

ATC

rosuvastatin; oral

0.7

10.1

465

6077

K81.0

ICD-10 Finland

Acute cholecystitis

2.6

10.1

211

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

10.1

223

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

10.1

226

1445

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

10.1

331

4601

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.8

10.1

142

798

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

3.5

10.1

D07AB08

ATC

desonide; topical

1.7

10.0

205

1280

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.5

10.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

10.0

214

1352

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.0

10.0

140

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.1

10.0

H36.01

ICD-10 Finland

Diabetic maculopathy

3.1

9.9

130

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

9.9

174

1043

Z94.0

ICD-10 Finland

Kidney transplant status

3.5

9.9

A10BX01

ATC

guar gum; oral

2.1

9.9

414

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

9.9

268

1792

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

16.8

9.9

EB4VA, ,

NOMESCO Finland

0.5

9.9

111

2008

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.1

9.8

449

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.4

9.8

293

M10.0

ICD-10 Finland

Idiopathic gout

2.0

9.8

490

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

9.8

181

1100

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.4

9.8

287

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.0

9.7

142

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.1

9.7

478

R31

ICD-10 Finland

Unspecified haematuria

1.6

9.7

253

1677

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

13.4

9.7

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

55.2

9.6

K76.4

ICD-10 Finland

Peliosis hepatis

55.2

9.6

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

5.3

9.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

9.6

153

891

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

9.6

128

706

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

9.6

382

2768

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.5

9.6

235

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

9.5

414

3049

2BD01, ,

NOMESCO Finland

15.1

9.5

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.1

9.5

123

K02.9

ICD-10 Finland

Dental caries, unspecified

2.9

9.5

150

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.3

9.4

298

SPAT1251

SPAT

Organisation of medication

2.3

9.4

330

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.6

9.4

201

5716A

ICD-9 Finland

Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]

100.5

9.4

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.7

9.4

184

B02AA02

ATC

tranexamic acid; systemic

1.6

9.4

222

1437

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

30.1

9.4

N06AB10

ATC

escitalopram; oral

1.5

9.4

325

2290

I98.2

ICD-10 Finland

Oesophageal varices without bleeding in diseases classified elsewhere

+∞

9.4

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

5.2

9.4

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.6

9.4

196

I78.8

ICD-10 Finland

Other diseases of capillaries

12.4

9.4

J94.9

ICD-10 Finland

Pleural condition, unspecified

4.9

9.3

L28.1

ICD-10 Finland

Prurigo nodularis

4.5

9.3

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

9.3

105

549

M10

ICD-10 Finland

Gout

1.9

9.2

116

628

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3.8

9.2

R40.2

ICD-10 Finland

Coma, unspecified

3.8

9.2

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

9.2

366

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

9.2

191

1197

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.3

9.2

105

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

9.2

246

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.3

9.1

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

9.1

408

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

9.1

192

1209

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.5

9.1

211

M01AH05

ATC

etoricoxib; oral

0.8

9.1

937

10882

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

4.6

9.1

R04.2

ICD-10 Finland

Haemoptysis

2.1

9.1

429

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.2

9.1

323

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

9.0

144

840

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

9.1

9.0

D02AX

ATC

Other emollients and protectives

2.4

9.0

254

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

9.0

144

841

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

9.0

130

737

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

9.0

107

570

ZXD35

NOMESCO Finland

Usual procedure

2.2

9.0

318

SPAT1301

SPAT

No procedures

1.4

8.9

606

4807

212

Kela drug reimbursment

Gout

2.5

8.9

225

OAB50, ,

SPAT

1.6

8.9

185

1161

K63.5

ICD-10 Finland

Polyp of colon

2.3

8.9

275

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.7

8.8

C08CA01

ATC

amlodipine; oral

1.3

8.8

870

7290

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

8.8

206

1330

N40

ICD-10 Finland

Hyperplasia of prostate

0.7

8.8

349

4702

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.1

8.8

113

N30.0

ICD-10 Finland

Acute cystitis

1.5

8.8

283

1964

E000006, ,

ATC

1.8

8.8

124

698

SPAT1211

SPAT

Application of soft bandage

1.7

8.8

171

1055

R10.0

ICD-10 Finland

Acute abdomen

2.3

8.7

296

N06AB03

ATC

fluoxetine; oral

1.6

8.7

225

1488

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

8.7

107

576

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.1

8.7

114

J02AC01

ATC

fluconazole; systemic

1.4

8.7

615

4910

OAA80, ,

SPAT

0.3

8.7

844

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

7.7

8.6

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

8.6

110

599

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.3

8.6

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.3

8.6

N05AB01

ATC

dixyrazine; systemic

3.3

8.6

EB1WA, ,

NOMESCO Finland

4.6

8.6

RJ411, ,

NOMESCO Finland

4.8

8.6

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.6

406

3032

XF622

NOMESCO Finland

Measurement of minute volume of heart

6.9

8.5

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

3.1

8.5

110

A10BD08

ATC

metformin and vildagliptin; systemic

3.4

8.5

N03AX14

ATC

levetiracetam; systemic

2.3

8.5

293

E83.51

ICD-10 Finland

Hypocalcemia

4.2

8.5

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

90.4

8.4

K74.4

ICD-10 Finland

Secondary biliary cirrhosis

90.4

8.4

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

8.4

483

V03AE02

ATC

sevelamer; oral

4.5

8.4

A02BC05

ATC

esomeprazole; systemic

1.3

8.4

799

6652

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.9

8.4

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

4.7

8.3

SPAT1269

SPAT

Other puncture and/or drainage

4.7

8.3

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

8.3

JJ9AT

NOMESCO Finland

Sampling of liver transplant under radiological guidance

+∞

8.3

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

8.3

527

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

8.6

8.3

F60.2

ICD-10 Finland

Dissocial personality disorder

10.8

8.3

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.4

8.2

E000003, ,

ATC

2.1

8.2

397

N18.0

ICD-10 Finland

End-stage renal disease

3.3

8.2

A29

ICPC

General symptom/complaint other

1.5

8.2

278

1949

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

8.2

324

SPAT1139

SPAT

Nutrition survey

2.1

8.2

344

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.9

8.2

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

4.4

8.1

N05BA02

ATC

chlordiazepoxide; systemic

2.4

8.1

241

TGC00

NOMESCO Finland

Bronchial lavation

2.3

8.1

279

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

8.1

158

974

I95.2

ICD-10 Finland

Hypotension due to drugs

3.6

8.1

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

8.1

107

590

K80

ICD-10 Finland

Cholelithiasis

3.2

8.1

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

8.1

193

D23

ICPC

Hepatomegaly

33.5

8.1

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.0

8.1

L30.3

ICD-10 Finland

Infective dermatitis

2.1

8.1

366

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.9

8.1

107

591

B01AB10

ATC

tinzaparin; parenteral

1.5

8.0

233

1580

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

8.9

8.0

RS122, ,

NOMESCO Finland

10.1

8.0

S10

ICPC

Boil/carbuncle

1.8

8.0

121

695

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

6.3

8.0

A03

ICPC

Fever

1.5

8.0

279

1967

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.1

8.0

104

WW200

NOMESCO Finland

Immunization

2.3

8.0

256

ZY010

NOMESCO Finland

Hospital outpatient

2.0

8.0

457

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

7.3

8.0

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.3

7.9

R06

ICPC

Nose bleed/epistaxis

2.3

7.9

263

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.4

7.9

SPAT1281

SPAT

Other administrative function

1.7

7.9

151

928

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

7.9

249

1721

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

7.9

174

1109

Z71.8

ICD-10 Finland

Other specified counselling

1.3

7.8

620

5016

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

6.1

7.8

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

7.8

184

1190

S29

ICPC

Skin symptom/complaint other

1.4

7.8

404

3060

L85.3

ICD-10 Finland

Xerosis cutis

3.2

7.8

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

7.8

227

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

8.5

7.8

L84

ICD-10 Finland

Corns and callosities

2.0

7.8

398

N06AA09

ATC

amitriptyline; systemic

1.6

7.8

186

1207

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.2

7.8

291

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

7.8

229

1559

S20.2

ICD-10 Finland

Contusion of thorax

1.8

7.7

114

651

SPAT1122

SPAT

Ascites puncture

45.1

7.7

JJA43

NOMESCO Finland

Destruction of lesion of liver

45.1

7.7

602

Kela drug reimbursment

Children's severe malnutrition

15.1

7.7

KGH10

NOMESCO Finland

Operation for phimosis

2.1

7.7

312

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

7.7

332

318

Kela drug reimbursment

Teriparatide

4.5

7.6

K50.8

ICD-10 Finland

Other Crohn disease

2.9

7.6

123

176

Kela drug reimbursment

Regorafenib

6.7

7.6

TJA00

NOMESCO Finland

Puncture of peritoneum

25.1

7.6

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

7.5

725

6021

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

7.5

369

2769

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

7.5

474

A08AB01

ATC

orlistat; oral

3.7

7.5

K85

ICD-10 Finland

Acute pancreatitis

2.6

7.5

159

N06AX16

ATC

venlafaxine; oral

1.5

7.5

233

1606

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

7.4

165

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.9

7.4

H02AB09

ATC

hydrocortisone; systemic

2.3

7.4

226

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

7.4

365

2743

J01AA02

ATC

doxycycline; systemic

1.3

7.4

1590

14631

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.3

7.4

246

TJX10

NOMESCO Finland

Koagulation of bleeding or bloodvessel with lokal diatermy in gastrointestinal endoscopy

+∞

7.3

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

10.9

7.3

XX2RW, ,

NOMESCO Finland

2.8

7.3

132

K29.1

ICD-10 Finland

Other acute gastritis

2.9

7.3

110

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

7.3

161

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.8

7.3

530

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.2

7.2

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.4

7.2

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.3

7.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

7.2

381

2892

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

6.2

7.2

M46.4

ICD-10 Finland

Discitis, unspecified

5.8

7.2

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.5

7.2

30041

ICD-8 Finland

Neuroses, Depressiva

2.8

7.2

122

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.9

7.2

111

SPAT1260

SPAT

Consultation of another employee

1.4

7.2

333

2475

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

7.2

411

L04AA10

ATC

[U] sirolimus

30.1

7.1

SPAT1172

SPAT

Guidance concerning hydration

2.4

7.1

205

A41.2

ICD-10 Finland

Sepsis due to unspecified staphylococcus

20.1

7.1

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

7.1

203

1372

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

7.1

117

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.4

7.1

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

7.1

102

578

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

7.1

554

4464

Z94.1

ICD-10 Finland

Heart transplant status

7.9

7.1

742, ,

NOMESCO Finland

7.9

7.1

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

7.1

296

CL2S4, ,

SPAT

2.2

7.1

244

N05BE01

ATC

buspirone; oral

2.2

7.1

270

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.6

7.1

C07AA07

ATC

sotalol; systemic

2.0

7.1

406

D07AC13

ATC

mometasone; topical

1.3

7.0

544

4379

K11.70

ICD-10 Finland

Hypoptyalism

4.2

7.0

SAA04

NOMESCO Finland

Special examination of mouth

1.8

7.0

551

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.3

7.0

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.0

7.0

102

S01.0

ICD-10 Finland

Open wound of scalp

1.6

7.0

174

1142

C07AB03

ATC

atenolol; systemic

1.7

7.0

123

740

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.9

691

5752

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

6.9

150

951

WX722

NOMESCO Finland

PEEP

1.8

6.9

106

613

T82

ICPC

Obesity

2.0

6.9

333

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.5

6.9

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

7.5

6.9

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

4.0

6.9

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

6.9

269

1938

N02AC04

ATC

dextropropoxyphene; oral

1.9

6.9

410

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.2

6.8

512

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

8.3

6.8

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

6.8

682

5679

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.8

6.8

T45

ICPC

Metabolic, Observ/health educat/advice/diet

2.6

6.8

143

A02BA03

ATC

famotidine; systemic

1.9

6.8

426

2BB01, ,

NOMESCO Finland

40.2

6.8

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

40.2

6.8

L04AA05

ATC

[U] tacrolimus

16.7

6.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

6.7

136

848

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.6

6.7

138

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

3.5

6.7

SPAT1252

SPAT

Overall medication plan or its review

1.6

6.7

141

888

H26.3

ICD-10 Finland

Drug-induced cataract

3.9

6.7

H3602, E113,

ICD-10 Finland

7.2

6.7

K29.8

ICD-10 Finland

Duodenitis

3.2

6.7

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.5

6.7

156

G03FA01

ATC

norethisterone and estrogen; systemic

0.5

6.7

1422

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

6.7

140

881

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

6.7

133

827

TPH04, ,

SPAT

3.0

6.7

D10

ICPC

Vomiting

1.9

6.6

394

JFB00

NOMESCO Finland

Partial resection of small intestine

2.6

6.6

145

SPAT1054

SPAT

Examination of peripheral nervous system

2.5

6.6

169

D91

ICPC

Abdominal hernia other

2.7

6.6

122

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

5.5

6.6

A07AA02

ATC

nystatin; oral

1.7

6.6

115

690

JJB71

NOMESCO Finland

Laparoscopic resection of liver

12.3

6.6

AN1

Coronary angiography

1.4

6.6

248

1774

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.8

6.5

526

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

6.5

977

8534

NHQ40

NOMESCO Finland

Amputation of toe

2.5

6.5

164

A12AA04

ATC

calcium carbonate; oral

2.5

6.5

158

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

6.9

6.5

57309

ICD-8 Finland

Other diseases of liver, Unspecified

6.9

6.5

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

6.5

186

1259

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.2

6.5

247

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.9

6.4

377

RS321, ,

NOMESCO Finland

70.1

6.4

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

70.1

6.4

L04AA18

ATC

[U] everolimus

70.1

6.4

JCA35

NOMESCO Finland

Endoscopic contact coagulation in oesophagus

70.1

6.4

W19

ICD-10 Finland

Unspecified fall

1.5

6.4

190

1295

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2.7

6.4

124

C01DA14

ATC

isosorbide mononitrate; oral

1.4

6.4

335

2537

SPAT1104

SPAT

Monitoring of emergency patient

1.6

6.4

129

804

XFP02, ,

NOMESCO Finland

14.3

6.4

SPAT1234

SPAT

Support of social functional capacity

1.7

6.4

103

605

H26.02

ICD-10 Finland

Presenil cataract

2.1

6.4

275

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.6

6.4

142

N06AB05

ATC

paroxetine; oral

1.8

6.4

553

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.0

6.4

316

D09AB01

ATC

zinc bandage without supplements; topical

2.4

6.3

185

XF612

NOMESCO Finland

Measurement of central venous pressure

8.2

6.3

C02LM02, ,

ATC

2.8

6.3

108

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

6.3

166

1103

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

2.4

6.3

167

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.4

6.3

161

XX4BW, ,

NOMESCO Finland

9.3

6.3

J04AB02

ATC

rifampicin; systemic

2.7

6.3

114

R5110, ,

SPAT

1.5

6.3

180

1219

XX9TE

NOMESCO Finland

Compementary ultrasound examination

3.9

6.3

5711A

ICD-9 Finland

Chronic liver disease and cirrhosis, Acute alcoholic hepatitis

+∞

6.3

5710A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic fatty liver

+∞

6.3

B18.9

ICD-10 Finland

Chronic viral hepatitis, unspecified

+∞

6.3

L04AH02

ATC

everolimus; oral

+∞

6.3

PH3YT

NOMESCO Finland

Insertion of catheter from portal vein to liver vein (TIPS)

+∞

6.3

Q20.48

ICD-10 Finland

Single ventricle

+∞

6.3

D06AX11

ATC

rifaximin; topical

+∞

6.3

N05CF02

ATC

zolpidem; oral

1.4

6.2

302

2258

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

6.2

351

2690

WW500, ,

SPAT

26.7

6.2

G92

ICD-10 Finland

Toxic encephalopathy

26.7

6.2

5718X

ICD-9 Finland

Chronic liver disease and cirrhosis, Other chronic nonalcoholic liver disease

26.7

6.2

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

26.7

6.2

7AX01, ,

NOMESCO Finland

26.7

6.2

N05BB01

ATC

hydroxyzine; systemic

1.7

6.2

104

617

N06AB06

ATC

sertraline; oral

1.5

6.2

174

1172

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.2

549

4489

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

6.2

1396

12751

T93

ICPC

Lipid disorder

0.5

6.2

1057

WPA11

NOMESCO Finland

Developing a plan for palliative care

6.3

6.2

P01AB01

ATC

metronidazole; oral, rectal

1.3

6.1

711

6013

C08CA02

ATC

felodipine; oral

1.5

6.1

198

1374

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

7.7

6.1

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

6.1

935

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

6.1

141

909

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.5

6.1

145

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

6.1

237

1705

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.8

6.1

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

12.5

6.1

A08AA02

ATC

fenfluramine; oral

3.0

6.1

I78.0

ICD-10 Finland

Hereditary haemorrhagic telangiectasia

8.6

6.1

J96.0

ICD-10 Finland

Acute respiratory failure

2.6

6.0

128

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.0

1077

9566

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

2.6

6.0

134

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.6

6.0

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

10.0

6.0

D01

ICPC

Abdominal pain/cramps general

1.5

6.0

206

1447

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006922) Hepatitis E virus Ab [Presence] in Serum

242

120

22.54

322.31

1.1

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

320

274

13.50

321.35

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1873

9460

7.68

311.61

15.8

5.2

31.74

35.37

g/l

116.47

1843

8882

(3005719) IgG [Mass/volume] in Serum or Plasma

1195

1491

16.40

307.65

2.2

3.0

13.60

10.50

g/l

50.43

1132

1377

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1195

1997

11.94

307.65

1.7

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1623

6596

6.60

307.65

10.1

3.2

51.39

36.01

u/l

7.43

1587

6224

(3020779) Urea [Moles/volume] in Serum or Plasma

848

2170

5.74

307.65

12.7

7.5

11.50

10.31

mmol/l

3.81

825

2085

(3037522) Nuclear Ab [Titer] in Serum

1173

2474

9.04

307.65

1.5

1.3

450.78

526.97

titre

0.71

293

534

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

427

115

45.86

307.65

1.1

1.0

289.42

288.92

mg/l

0.02

393

103

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1288

3209

8.29

307.65

3.7

2.8

23.66

22.66

1.10

1247

3000

(3017143) Hepatitis C virus Ab [Presence] in Serum

1097

1778

11.33

307.65

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1208

3550

6.34

307.65

1.9

1.5

4.49

2.50

g/l

83.10

1071

2115

(3023487) Leukocytes [#/volume] in Peritoneal fluid

382

85.44

307.65

2.7

1.8

375.66

1132.69

e6/l

2.06

253

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

875

231

62.32

307.65

3.9

2.1

1539.41

183.52

u/ml

0.67

861

226

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1466

2066

19.35

307.65

5.3

2.1

0.16

0.21

g/l

100.71

1346

1933

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1056

2331

7.80

307.65

8.3

2.7

16.27

8.26

umol/l

14.16

997

2090

(3022948) Iron [Moles/volume] in Serum or Plasma

1337

3683

7.73

307.65

3.8

2.8

12.54

12.79

umol/l

0.52

1287

3446

(3034770) Mitochondria Ab [Titer] in Serum

1102

433

50.10

307.65

1.3

1.2

829.58

1727.50

titre

0.93

(4281824) Cell count and differential, peritoneal fluid

302

164

21.19

307.65

1.4

1.1

—

(40768441) Liver Pathology biopsy report

344

131

30.95

307.65

2.3

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

457

138

41.56

307.65

1.3

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

274

148

21.01

307.65

1.3

1.2

238.44

125.00

titre

0.73

(3007566) Smooth muscle Ab [Titer] in Serum

1123

440

51.21

307.65

1.4

1.2

96.78

107.00

titre

0.20

118

(3028026) IgM [Mass/volume] in Serum or Plasma

1138

1157

19.35

307.65

1.6

1.9

1.52

1.37

g/l

0.83

1068

1063

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

655

232

39.82

307.65

1.2

1.1

1.65

1.52

g/l

4.95

609

213

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1308

3449

7.91

307.65

3.7

2.8

2.30

2.28

g/l

0.41

1245

3204

(3026692) Albumin [Mass/volume] in Peritoneal fluid

350

101.37

307.65

1.7

1.1

11.10

16.13

g/l

2.75

252

(3002331) Protein [Mass/volume] in Peritoneal fluid

291

108.07

307.65

1.5

1.3

41.91

32.93

g/l

0.17

210

(3044007) Cell count panel - Peritoneal fluid

324

80.70

307.65

2.4

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

888

2052

6.59

307.65

2.4

1.8

1.69

1.56

4.70

748

1773

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

440

472

11.41

307.65

1.3

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1015

409

45.30

307.65

5.8

1.8

45.44

33.58

umol/l

4.98

979

354

(44816559) Phosphatidylethanol [Mass/volume] in Blood

725

735

14.24

307.65

2.5

1.6

0.34

0.33

mg/l

0.04

301

349

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

330

82.46

307.65

2.5

1.5

11860.54

4739.34

e6/l

0.51

164

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

316

292

12.47

301.87

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

221

104

23.52

300.48

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

331

352

10.90

286.87

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

585

1211

6.22

282.09

1.4

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

159

45.03

267.44

3.8

1.8

404.11

95.79

ug/l

0.55

159

(3042936) Bacteria identified in Isolate by Culture

942

3097

4.58

259.31

3.3

2.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

912

2990

4.51

250.61

9.2

6.4

1.10

1.03

mmol/l

6.42

864

2788

(3032080) INR in Blood by Coagulation assay

1838

10218

5.91

240.95

29.9

16.8

1.39

1.29

inr

13.31

1622

8524

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1019

3714

4.25

240.54

5.5

3.5

0.77

0.82

mmol/l

27.38

976

3514

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1898

10955

6.41

233.94

22.7

6.7

24.35

11.70

umol/l

53.44

1880

10478

(3033658) Prothrombin time (PT) actual/Normal

1239

5289

4.08

231.14

16.2

4.2

66.49

86.73

125.45

1207

5191

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

375

606

7.26

228.88

2.2

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1262

5488

4.06

228.39

3.8

2.3

3.79

2.84

mg/l

22.71

1174

4713

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

819

2726

4.20

215.51

3.7

4.5

240.56

246.04

u/l

0.47

798

2599

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

436

873

5.98

214.19

3.3

3.5

137.60

4927.27

u/ml

0.90

395

755

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

485

1109

5.33

205.11

2.2

1.8

1.01

1.56

g/l

29.60

417

970

(40768797) Stomach Pathology biopsy report

819

2835

4.01

201.97

1.5

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1358

6570

3.80

201.66

5.2

2.7

60.02

73.86

u/l

0.56

1308

6082

(3027945) Reticulocytes/Erythrocytes in Blood

799

2744

4.01

198.84

3.4

2.6

2.31

1.78

20.53

745

2452

(3018677) aPTT in Platelet poor plasma by Coagulation assay

913

3464

3.80

195.73

3.3

2.1

32.29

29.70

22.32

886

3373

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1573

8532

3.98

192.75

5.7

3.1

195.21

151.61

ug/l

4.68

1527

7892

(3021447) Carbon dioxide [Partial pressure] in Venous blood

728

2409

4.03

189.91

6.3

3.8

5.52

5.83

kpa

11.56

707

2342

(3012544) pH of Venous blood

732

2432

4.02

189.85

6.3

3.8

7.37

7.38

0.97

447

1362

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

270

378

8.00

186.35

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

256

338

8.44

185.69

1.4

1.3

326.51

271.71

u/ml

1.28

148

192

(3002032) Base excess in Venous blood by calculation

707

2342

3.98

183.35

6.3

3.8

0.97

1.82

mmol/l

5.46

588

2034

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

706

2389

3.88

176.72

3.5

4.4

5.36

24.43

ug/l

3.58

625

1973

(3042733) HLA Ab [Presence] in Serum

129

22.04

172.81

1.7

5.1

—

(3023368) Bacteria identified in Blood by Culture

1261

6266

3.38

169.95

7.5

4.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

138

17.67

166.94

43.0

37.5

7.13

6.98

ug/l

0.29

126

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

133

18.81

165.95

4.7

2.2

0.58

0.61

mmol/l

2.66

133

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

241

338

7.89

165.63

1.4

1.5

143.81

157.47

au/ml

0.57

105

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

271

443

6.84

161.82

8.4

5.3

917.70

588.31

iu/ml

0.33

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

932

3954

3.36

161.64

1.4

1.3

2.52

1.44

u/ml

0.89

205

1051

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

500

1402

4.32

161.48

5.7

3.9

23.25

24.22

mmol/l

7.24

489

1386

(3000991) Gas panel - Venous blood

628

2076

3.84

160.94

14.0

9.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

279

482

6.49

157.73

1.4

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

637

2156

3.75

157.24

3.7

2.7

82.07

69.04

e9/l

9.21

482

1584

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

321

658

5.54

151.43

5.5

3.5

1.87

1.63

mg/l

4.43

307

592

(3020630) Protein [Mass/volume] in Serum or Plasma

592

1952

3.78

151.32

2.0

2.9

66.00

66.31

g/l

0.36

562

1801

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

122

17.40

146.80

1.7

1.5

1809232.11

1742174.83

iu/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

588

1975

3.70

145.64

4.1

2.5

32.75

64.48

u/l

0.71

523

1671

(3024980) IgG subclass 4 [Mass/volume] in Serum

214

309

7.57

142.93

1.5

1.6

1.06

0.86

g/l

1.03

188

239

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

157

155

10.83

141.58

1.1

—

(42870588) Differential panel, method unspecified - Blood

1279

6965

3.00

136.95

10.1

6.4

—

(3024471) HLA-A [Type]

107

19.68

136.82

1.0

—

(3024932) HLA-DR beta [Type]

106

19.84

136.04

1.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

596

2131

3.47

132.72

12.2

8.4

1.85

1.35

mmol/l

11.60

583

2093

(46235355) HIV 1 and 2 tests - Meaningful Use set

640

2409

3.34

130.96

1.8

1.6

—

(3006315) Basophils [#/volume] in Blood

1619

10215

3.23

129.73

10.8

6.4

0.04

e9/l

2.32

1418

8682

(3001604) Monocytes [#/volume] in Blood

1616

10187

3.22

129.65

10.8

6.4

0.58

0.61

e9/l

2.96

1417

8659

(3019069) Monocytes/Leukocytes in Blood

1534

9410

3.09

128.86

11.5

6.8

9.81

9.10

14.23

1483

8788

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

279

581

5.36

128.61

3.2

2.5

226.53

202.12

3.40

273

555

(3019198) Lymphocytes [#/volume] in Blood

1633

10383

3.24

128.48

10.9

6.5

1.57

1.90

e9/l

5.47

1451

9061

(3044640) Blood type and Crossmatch panel - Blood

1224

6664

2.89

128.35

4.8

2.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

103

12.81

126.76

1.9

1.4

—

(3018010) Neutrophils/Leukocytes in Blood

1524

9373

3.05

126.26

11.1

6.6

59.49

57.84

6.16

1487

8934

(3006504) Eosinophils/Leukocytes in Blood

1526

9397

3.05

126.03

11.3

6.7

3.01

2.86

1.83

1476

8775

(3022096) Basophils/Leukocytes in Blood

1525

9391

3.04

125.88

11.4

6.8

0.71

0.67

1.79

1475

8770

(3002030) Lymphocytes/Leukocytes in Blood

1542

9557

3.06

125.71

11.5

6.7

24.02

26.79

19.61

1499

9035

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1808

12356

3.63

122.75

12.6

3.3

177.69

52.18

u/l

108.35

1760

11528

(3013115) Eosinophils [#/volume] in Blood

1630

10520

3.13

121.43

11.3

6.6

0.18

0.20

e9/l

3.76

1442

9108

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

256

519

5.45

121.41

2.8

3.5

2501.61

856.07

u/ml

0.31

237

484

(3010375) cycloSPORINE [Mass/volume] in Blood

109

13.94

116.63

36.8

28.4

133.75

122.68

ug/l

0.60

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

205

350

6.36

116.45

2.6

2.9

908.27

1554.65

u/ml

0.26

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1633

10672

3.07

116.44

15.6

7.9

1.19

1.21

mmol/l

32.31

1478

9195

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

150

182

8.77

115.70

2.4

2.3

39.36

39.80

iu/ml

0.01

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

196

331

6.40

112.48

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

256

559

5.05

111.25

1.8

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

664

2779

2.99

110.79

12.2

8.6

4.81

5.11

kpa

11.34

640

2681

(3027801) Oxygen [Partial pressure] in Arterial blood

664

2780

2.99

110.71

12.2

8.6

11.71

12.05

kpa

1.12

642

2682

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

464

1580

3.46

109.73

2.2

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

993

5153

2.69

109.35

4.5

2.6

—

(3036489) Thrombin time

305

779

4.39

109.09

3.0

2.1

23.24

21.25

3.96

294

713

(3019977) pH of Arterial blood

659

2778

2.96

108.18

12.3

8.6

7.42

7.41

0.25

310

1542

(3013650) Neutrophils [#/volume] in Blood by Automated count

1688

11452

3.05

108.05

14.6

9.9

3.89

4.21

e9/l

5.09

1519

9899

(3016502) Oxygen saturation in Arterial blood

615

2516

3.01

106.36

12.6

8.8

95.55

95.51

0.05

599

2431

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

129

145

9.39

105.52

1.2

88.20

84.50

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1502

9660

2.76

105.17

13.9

7.2

1.18

1.21

mmol/l

37.90

1454

8909

(3018418) pH of Serum or Plasma

1135

6423

2.59

102.73

7.0

4.5

7.40

5.47

859

4678

(3003396) Base excess in Arterial blood by calculation

644

2763

2.88

101.46

12.4

8.5

-0.22

0.91

mmol/l

7.31

534

2293

(3024354) Oxygen [Partial pressure] in Venous blood

522

2017

3.08

99.14

5.7

3.1

4.66

4.53

kpa

0.71

498

1958

(3002173) Hemoglobin [Mass/volume] in Arterial blood

569

2348

2.92

95.68

13.5

9.3

110.68

121.89

g/l

25.99

561

2291

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

415

1434

3.34

94.85

14.6

10.7

23.48

24.27

mmol/l

4.30

403

1413

(3001186) Copper [Moles/volume] in Serum or Plasma

17.86

93.22

1.3

1.0

16.43

15.78

umol/l

0.37

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

774

3794

2.61

92.45

2.4

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

14.52

92.41

1.1

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

139

201

7.32

92.14

1.3

1.2

46.95

62.49

u/l

1.41

132

181

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

43.37

91.87

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

289

804

3.99

91.48

3.8

3.0

0.28

0.34

iu/ml

2.76

162

433

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

709

3481

2.53

82.81

3.7

3.3

2.52

1.76

e6/l

1.32

375

1747

(3030467) Casts [#/volume] in Urine by Automated count

1033

6007

2.36

82.55

4.4

3.4

0.78

0.39

e6/l

4.28

792

4475

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1417

9451

2.41

82.11

5.3

2.9

—

estimate

—

(3002582) Erythrocytes [#/volume] in Urine

1148

7000

2.34

81.92

4.7

3.5

52.67

81.00

e6/l

1.10

896

5424

(3026782) Osmolality of Urine

788

4091

2.44

81.23

4.0

3.0

502.18

541.16

mosm/kgh2o

5.68

711

3592

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

408

1525

3.06

80.75

4.9

3.8

4.84

5.15

kpa

9.41

395

1466

(3013826) Glucose [Moles/volume] in Serum or Plasma

1695

12313

2.65

80.58

13.4

5.5

7.78

6.83

mmol/l

37.04

1668

11806

(3019309) Folate [Moles/volume] in Red Blood Cells

730

3680

2.47

80.08

2.0

1.8

1236.21

1163.76

nmol/l

1.08

599

2804

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

16.98

79.07

1.1

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

364

1292

3.18

78.63

4.7

3.7

0.97

1.85

mmol/l

2.61

246

952

(3009343) pH of Capillary blood

396

1484

3.04

77.82

4.9

3.9

7.41

7.42

1.00

356

1232

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

607

2871

2.54

75.76

2.2

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

242

682

3.86

74.71

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

965

5636

2.27

74.11

4.4

3.0

394.62

355.39

umol/l

18.49

862

4951

(3020682) Albumin/Creatinine [Ratio] in Urine

1184

7590

2.22

71.39

5.3

4.3

14.87

8.08

mg/mmol

4.02

878

4874

(3018095) Leukocytes [#/volume] in Urine

1203

7765

2.22

71.24

5.6

4.1

105.10

106.12

e6/l

0.02

912

5632

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

569

2689

2.51

70.49

2.2

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

1184

7675

2.18

68.33

4.5

3.5

7.04

7.72

mmol/l

6.84

1030

6470

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

718

3811

2.31

68.11

3.5

3.1

1.33

0.96

e6/l

1.93

385

2092

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1920

15413

2.96

64.83

27.4

8.6

127.94

79.74

u/l

130.93

1894

14674

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

358

1395

2.87

64.78

15.2

11.4

14.58

16.01

15.20

352

1345

(3026008) Bacteria identified in Urine by Culture

980

6007

2.14

64.07

4.2

3.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1006

6230

2.13

64.01

2.3

1.7

18.56

20.04

nmol/l

2.70

927

5242

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1097

7030

2.12

63.68

4.4

3.2

1975.53

1402.75

ng/l

2.98

1001

6112

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

255

828

3.35

63.18

1.7

4.0

57.39

75.66

mg/l

0.44

214

717

(3012516) Albumin [Mass/volume] in Urine

1143

7467

2.11

62.72

4.2

3.6

85.91

45.22

mg/l

5.28

862

4916

(3034860) Kappa light chains.free [Mass/volume] in Serum

254

829

3.33

62.38

1.7

4.0

74.62

56.84

mg/l

1.35

213

715

(3007853) Bacteria identified in Skin by Aerobe culture

510

2421

2.44

61.59

2.1

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

259

863

3.27

61.47

2.1

2.0

49.23

38.57

u/l

6.70

230

754

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

204

586

3.74

60.94

1.6

1.3

6.96

8.49

iu/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

234

741

3.42

60.25

1.6

3.8

1.76

3.42

ratio

1.31

128

431

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

240

776

3.35

59.76

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

274

971

3.08

58.50

1.6

2.6

6.90

7.38

g/l

4.53

257

894

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

274

971

3.08

58.50

1.6

2.6

4.39

4.14

g/l

3.19

257

895

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

970

3.07

58.00

1.6

2.6

4.44

3.68

g/l

9.28

257

895

(3009445) Proteinase 3 Ab [Units/volume] in Serum

262

927

3.07

56.00

1.6

16.68

24.70

iu/ml

0.32

(3034274) Bile acid [Moles/volume] in Serum --fasting

8.62

55.95

3.1

1.5

30.25

8.79

umol/l

4.34

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

179

503

3.79

55.11

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

345

1432

2.67

54.72

2.0

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

274

1009

2.96

54.51

2.3

2.0

2.39

1.74

ug/l

0.56

250

899

(3002179) Metamyelocytes/Leukocytes in Blood

407

1834

2.50

54.43

5.8

4.3

0.92

0.70

0.44

179

590

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

747

4336

2.10

54.26

2.4

1.8

2.44

1.38

mg/l

6.77

661

3425

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1323

9431

2.01

53.68

2.9

2.2

93.74

94.41

pmol/l

0.18

758

5099

(3003181) Sodium [Moles/volume] in Urine

157

410

4.05

53.56

1.4

45.84

60.94

mmol/l

5.47

334

(3017181) Myelocytes/Leukocytes in Blood

418

1927

2.44

53.09

6.1

4.5

0.73

0.92

1.06

185

629

(3004119) Hemoglobin [Mass/volume] in Venous blood

354

1515

2.59

52.65

6.1

3.1

113.39

129.28

g/l

27.94

348

1472

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

848

3.08

52.48

1.6

2.7

13.92

10.31

g/l

14.22

224

766

(3000093) Morphology [Interpretation] in Blood Narrative

112

227

5.15

52.46

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

146

6.31

52.18

1.7

1.2

0.59

1.14

promille

2.69

115

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

906

3.00

51.65

1.6

2.7

2.94

g/l

0.00

235

830

(3027273) Bicarbonate [Moles/volume] in Venous blood

273

1056

2.81

49.41

6.1

3.2

24.14

25.27

mmol/l

4.10

263

1017

(3037756) Immunofixation for Serum or Plasma

173

512

3.58

49.24

1.2

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

453

2239

2.29

48.69

4.8

3.6

—

(3021589) Normoblasts [#/volume] in Blood

1237

8792

1.93

48.54

26.5

12.2

0.00

e9/l

0.39

1027

7165

(3021440) Promyelocytes/Leukocytes in Blood

394

1837

2.40

48.45

6.2

4.6

0.07

0.13

1.33

163

541

(3003434) Protein [Mass/volume] in Pleural fluid

133

337

4.14

47.21

1.7

1.5

27.06

32.18

g/l

3.84

120

304

(3021901) Oxygen saturation in Capillary blood

165

488

3.57

46.97

3.5

3.1

89.37

89.48

0.06

160

473

(3025159) Blasts/Leukocytes in Blood

390

1842

2.36

46.42

6.2

4.8

0.47

0.11

0.40

146

495

(3000850) Epithelial cells [#/volume] in Urine

792

4906

1.96

46.41

3.6

2.8

6.29

4.69

e6/l

2.33

740

4488

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

233

855

2.93

46.39

1.7

2.7

0.69

1.30

g/l

1.62

211

741

(3031040) Bacteria [#/volume] in Urine by Automated count

1626

12799

2.04

45.91

6.4

4.8

472.96

1338.95

e6/l

1.13

194

(3042111) Morphology [Interpretation] in Bone marrow Narrative

146

408

3.76

45.19

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

209

734

3.04

44.96

1.6

2.6

0.03

0.02

g/l

0.03

192

661

(4035726) Immunohistochemistry procedure

385

1832

2.34

44.93

1.7

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

224

825

2.91

44.24

2.6

2.3

1391.87

490.90

ug/l

1.39

211

787

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

204

714

3.05

44.12

1.6

2.6

0.01

0.00

g/l

0.50

182

627

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

194

663

3.11

43.72

1.6

2.6

0.00

g/l

-0.00

181

626

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

276

1141

2.62

43.63

1.6

1.5

—

(3012441) Differential panel - Pleural fluid

110

257

4.45

43.39

1.7

1.5

—

(3022313) Gas panel - Capillary blood

260

1049

2.68

43.14

5.3

4.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

120

6.26

42.69

1.7

1.6

12.22

5.84

u/l

1.14

103

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

148

438

3.55

42.04

1.2

1.6

0.94

0.82

nmol/l

0.97

120

368

(3000012) Reticulocyte production index

128

345

3.88

41.69

3.3

2.2

1.05

0.89

1.48

106

246

(3023420) DNA double strand Ab [Units/volume] in Serum

210

776

2.89

41.15

1.4

1.7

7.47

6.70

iu/ml

0.15

184

(36660697) Celiac disease serology panel - Serum

311

1400

2.42

40.92

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

706

4354

1.92

40.82

2.0

1.8

524.66

27665892.97

pmol/l

3.24

604

3611

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

345

1633

2.32

40.47

6.0

4.2

107.25

94.99

ng/l

1.15

305

1415

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

160

511

3.30

40.31

1.4

1.5

—

(1616796) Gas panel - Central venous blood

155

488

3.34

39.95

4.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

275

1195

2.49

38.99

7.8

3.8

46.05

48.04

0.63

270

1174

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1194

8774

1.79

38.28

3.8

2.4

71.80

77.90

nmol/l

10.15

1115

7833

(40760892) CBC W Ordered Manual Differential panel - Blood

683

4263

1.87

37.44

7.9

4.9

—

(3024928) Oxygen saturation in Venous blood

177

627

2.98

37.36

4.9

3.0

60.70

60.95

0.04

164

610

(3036481) Cortisol [Moles/volume] in Serum or Plasma

372

1874

2.19

37.32

2.1

2.3

355.16

378.60

nmol/l

0.86

355

1742

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

120

338

3.70

36.66

7.2

6.7

12.84

12.05

mg/l

0.97

106

317

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

354

1771

2.19

36.05

3.6

2.9

52.91

64.42

ml/min/173m2

4.38

163

762

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

8.65

35.30

1.7

1.3

13.09

8.90

ug/l

3.24

(40768806) Pleura Pathology biopsy report

252

4.02

34.05

1.8

1.6

—

(3022145) Colonoscopy Study observation

425

2331

2.02

33.76

1.6

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

108

302

3.71

33.34

1.8

1.4

1285.62

4421.63

e6/l

0.57

217

(3000494) Fungus identified in Specimen by Culture

449

2526

1.98

33.12

2.0

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

243

1073

2.42

33.06

6.8

5.5

1.78

1.60

2.25

232

1013

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

112

5.67

32.92

1.1

135.54

73.42

u/l

4.27

100

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

200

810

2.62

32.66

5.6

4.0

23.63

24.89

mmol/l

5.07

189

748

(3028308) Erythrocytes [#/volume] in Pleural fluid

262

3.83

31.47

1.8

1.4

19905.35

89376.26

e6/l

1.71

153

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

112

5.48

30.77

1.1

48.26

19.16

u/l

4.19

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

156

577

2.83

30.36

1.3

1.6

1.11

1.18

g/l

1.61

147

553

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

152

555

2.87

30.29

1.3

1.6

0.20

0.24

g/l

4.86

143

532

(3045788) Cell count panel - Pleural fluid

252

3.81

30.04

1.9

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

145

4.81

30.00

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

653

4264

1.76

29.50

5.0

4.2

472.58

668.54

ng/l

0.34

568

3557

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

180

4.34

29.45

1.6

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

140

4.83

29.30

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

345

1840

2.04

29.29

4.4

3.1

268.89

210.41

ng/l

1.54

322

1701

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

152

567

2.81

29.10

1.6

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

153

4.62

29.04

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

179

4.30

28.78

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

8.70

28.43

1.1

—

(3012501) Base excess in Blood by calculation

128

441

3.02

28.30

5.4

5.2

2.35

2.74

mmol/l

0.72

302

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

153

4.55

28.12

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

153

4.55

28.12

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.63

28.07

1.4

4.1

56.30

71.75

mg/l

0.73

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

111

5.25

27.92

2.7

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

217

981

2.34

27.86

7.1

5.8

0.83

0.87

0.76

207

923

(3027135) IgG subclass 1 [Mass/volume] in Serum

188

4.15

27.83

1.3

10.46

6.51

g/l

4.68

133

(3028192) IgG subclass 2 [Mass/volume] in Serum

188

4.15

27.83

1.3

3.28

2.88

g/l

0.83

133

(3024139) IgG subclass 3 [Mass/volume] in Serum

188

4.15

27.83

1.3

0.55

0.40

g/l

1.80

132

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

147

4.60

27.64

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

221

3.86

27.49

1.1

1.2

35.28

85.27

u/ml

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

4.42

27.48

1.1

—

(40758558) Short blood count panel - Blood

861

6167

1.65

27.03

10.9

6.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

24.14

27.01

1.6

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

116

389

3.09

26.87

1.2

131.43

476.11

titre

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

127

4.83

26.71

1.4

1.27

1.14

nmol/l

0.45

(3004809) Band form neutrophils/Leukocytes in Blood

113

375

3.12

26.65

3.4

3.9

1.63

1.59

0.03

102

335

(4062490) Immunoglobulin typing, IgG

188

4.04

26.16

1.2

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

921

6752

1.63

26.08

2.8

2.3

277.34

242.24

u/l

0.41

887

6397

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

122

4.86

26.02

1.9

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

122

4.86

26.02

1.9

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

6.72

25.97

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

314

1687

2.01

25.92

6.5

4.2

1.20

1.22

mmol/l

7.46

300

1467

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

189

832

2.39

25.73

2.5

2.7

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1694

14478

1.75

25.67

7.4

4.5

25.20

12.61

mm/h

89.01

1610

13510

(3008152) Bicarbonate [Moles/volume] in Arterial blood

283

1483

2.04

25.00

9.5

7.3

23.29

24.56

mmol/l

4.97

276

1418

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

122

441

2.87

24.75

1.1

1.2

1.30

5.65

u/ml

—

(21494434) Karyotype in Bone marrow

229

3.63

24.62

1.1

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1069

8218

1.59

24.23

6.1

4.1

91.81

67.96

ng/l

0.20

914

6292

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

132

4.49

23.67

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

134

525

2.65

23.31

1.2

20.93

3.40

u/ml

0.79

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

133

527

2.62

22.61

1.2

9.05

8.08

u/ml

0.05

(3052851) Hemolysis interference index of Serum or Plasma

144

594

2.52

22.54

5.2

3.4

2.29

2.11

index

0.14

314

(3015736) pH of Urine

1072

8335

1.56

22.51

4.4

3.6

6.27

6.22

0.58

524

4642

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

136

548

2.58

22.35

1.2

20.28

34.79

u/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

131

4.36

22.08

1.5

1.4

—

(4198724) Urine methamphetamine measurement

7.11

22.07

8.1

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

747

5366

1.59

22.04

3.7

3.1

0.07

0.02

0.34

131

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

149

632

2.46

21.98

1.7

1.6

34.84

17.65

u/ml

1.64

124

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

140

577

2.52

21.95

1.6

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1274

10344

1.55

21.68

5.3

4.0

0.00

estimate

0.50

337

2200

(3035350) Ketones [Presence] in Urine by Test strip

1286

10474

1.55

21.49

5.3

4.0

15.88

2.97

estimate

0.96

342

2237

(3009261) Glucose [Presence] in Urine by Test strip

1291

10534

1.55

21.31

5.4

4.0

6.88

0.16

estimate

0.78

292

2070

(3006184) Hemoglobin [Mass/volume] in Capillary blood

133

544

2.54

21.19

3.2

2.3

114.66

129.73

g/l

8.17

113

423

(3020876) Protein [Mass/time] in 24 hour Urine

276

3.16

20.82

1.8

2.5

1.02

1.34

g/24h

0.56

166

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

105

4.65

20.58

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

311

3.01

20.43

1.1

162.79

84.04

iu/ml

0.23

(3014148) Varicella zoster virus Ab [Titer] in Serum

188

3.59

19.87

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.91

19.69

1.2

1.5

76.42

92.48

umol/l

0.18

(3037121) Protein [Mass/volume] in Urine

164

762

2.25

19.63

3.1

3.4

330.51

369.52

mg/l

0.16

106

335

(3000570) Elastase.pancreatic [Mass/mass] in Stool

144

633

2.36

19.62

1.5

269.89

272.42

ug/g

0.04

401

(3009871) Measles virus Ab [Titer] in Serum

5.43

19.50

1.7

1.5

4160.00

4266.67

titre

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

105

398

2.72

19.49

1.2

92.46

51.80

u/ml

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

240

3.20

18.84

1.5

1.4

—

(3008838) Granulocytes/Leukocytes in Peritoneal fluid

+∞

18.77

1.8

0.0

28.20

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

129

555

2.41

18.44

2.5

2.3

124.15

100.93

ug/min

0.28

337

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

134

588

2.36

18.33

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

229

3.22

18.27

1.5

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

4.89

18.27

1.6

2.10

2.56

0.16

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

277

3.00

18.18

1.0

1.1

—

15.70

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

230

3.20

18.14

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

674

4898

1.54

18.14

4.3

3.8

0.00

0.12

1.24

(3015377) Calcium [Moles/volume] in Serum or Plasma

926

7202

1.49

18.02

4.2

3.6

2.31

2.35

mmol/l

11.19

850

6516

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

7.30

17.81

1.6

1.7

22.54

7.83

1.37

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.21

17.70

3.3

2.1

63455.57

3489.73

u/ml

—

(21494890) Protein electrophoresis panel - 24 hour Urine

245

3.09

17.57

1.4

2.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.54

17.54

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.54

17.54

1.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

156

3.66

17.45

5.5

2.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

238

3.09

17.15

1.5

1.4

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

4.44

17.09

1.6

1.5

62.66

61.28

0.08

(3024522) Salmonella sp identified in Specimen by Organism specific culture

239

3.08

17.03

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

229

3.12

16.97

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

356

2.68

16.96

1.1

1.3

192.50

206.03

miu/ml

0.10

135

(3016038) Potassium [Moles/volume] in Urine

145

3.72

16.96

1.1

1.2

38.64

35.61

mmol/l

0.35

130

(3035880) pH of Pleural fluid

142

3.73

16.69

1.5

1.4

7.41

7.40

0.10

101

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

160

789

2.11

16.48

2.1

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

247

2.98

16.10

7.2

5.5

8.52

7.41

mmol/l

1.38

206

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

403

2.53

15.96

1.7

1.8

—

(3003694) ABO and Rh group [Type] in Blood

717

5404

1.49

15.75

1.6

1.3

—

(3042631) Mycobacterium sp identified in Specimen

329

2.68

15.72

2.3

2.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1594

0.34

15.66

1.7

2.1

3.75

3.54

ratio

0.55

1299

(3051611) Lipemic interference index of Serum or Plasma

209

3.12

15.58

4.5

3.5

15.93

11.08

index

1.77

122

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

101

422

2.46

15.41

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

101

422

2.46

15.41

1.5

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

105

4.06

15.25

2.0

2.4

1319.83

1153.21

u/ml

0.21

105

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

166

859

2.01

15.01

2.4

1.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

31.92

14.80

2.6

3.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

288

2.73

14.72

1.5

1.7

—

(3017354) Segmented neutrophils/Leukocytes in Blood

251

2.85

14.49

3.1

3.8

61.67

57.20

0.85

215

(3025941) Bacteria identified in Stool by Culture

175

935

1.95

14.44

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

304

2.62

13.78

1.5

1.6

—

(21494755) Public health laboratory ask at order entry panel

1200

0.30

13.25

1.4

—

(3017569) Oxygen content in Arterial blood

136

3.43

13.18

2.0

2.5

14.31

16.37

3.08

136

(3045142) Bone marrow Pathology biopsy report

282

2.64

13.14

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

292

1877

1.64

12.81

3.3

2.5

1.04

0.47

e6/l

1.01

287

1798

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

11.06

12.52

1.0

—

(3004775) Volume in Urine collected for unspecified duration

172

3.07

12.45

2.3

2.2

708.24

645.08

0.36

111

(3017732) Neutrophils [#/volume] in Blood

368

2519

1.55

12.37

3.9

3.5

5.01

4.78

e9/l

0.15

330

2163

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

216

2.83

12.37

3.7

2.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

129

655

2.03

12.31

6.3

4.2

3.95

3.93

mmol/l

0.18

129

647

(1761868) Lipid panel - Serum or Plasma

509

6717

0.68

12.24

4.6

3.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

240

2.72

12.22

3.8

4.3

—

(3047181) Lactate [Moles/volume] in Blood

133

685

2.00

12.20

8.0

6.8

2.04

1.34

mmol/l

2.92

115

603

(3027456) Digoxin [Moles/volume] in Serum or Plasma

102

476

2.20

12.12

3.3

3.5

0.77

0.81

nmol/l

0.39

391

(3044927) Protein electrophoresis panel - Urine

242

2.69

12.03

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1110

0.32

11.68

1.6

1.8

3.09

3.47

mmol/l

1.07

815

(3008295) Osmolality of Serum or Plasma

235

2.69

11.61

1.3

276.52

275.94

mosm/kgh2o

0.06

171

(3019225) pH of Specimen

303

2013

1.59

11.56

7.0

4.5

7.38

7.36

1.42

265

1438

(3044242) Glucose [Moles/volume] in Arterial blood

146

3.13

11.15

1.6

2.2

8.90

8.07

mmol/l

0.60

146

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

513

2.10

11.13

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

118

603

2.01

11.08

1.5

0.35

13.17

iu/ml

0.56

103

(3048689) Calprotectin [Mass/mass] in Stool

322

2195

1.55

10.95

2.9

2.5

192.88

155.04

ug/g

1.02

276

1768

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

172

2.89

10.62

1.5

1.6

31.00

26.55

u/ml

0.25

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

458

2.12

10.44

1.3

48.98

41.61

u/l

0.24

389

(1761482) Bacteria [#/volume] in Urine by Culture

100

492

2.08

10.42

6.2

4.5

—

(3002256) Pathology report gross observation

385

2754

1.48

10.38

1.4

1.3

—

(40768804) Tissue Pathology biopsy report

929

7743

1.35

10.21

2.6

2.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

446

2.11

9.98

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

599

7489

0.72

9.92

3.6

4.7

22.62

21.84

0.46

249

3814

(3013945) Hepatitis B virus e Ab [Presence] in Serum

12.23

9.85

1.4

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.87

9.68

1.3

10.67

64.73

ug/l

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

554

4290

1.39

9.59

3.5

3.1

2.50

2.45

mmol/l

11.45

494

3862

(1001926) Buprenorphine [Presence] in Urine by Screen method

271

2.40

9.59

6.1

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

4.04

9.51

2.5

1.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

183

2.72

9.50

1.6

1.7

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

7.56

9.41

1.0

1.3

13.81

23.06

u/l

0.69

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

7.56

9.41

2.5

2.8

58.12

32.77

mg/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

243

2.47

9.40

7.2

2.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

290

1999

1.52

9.31

2.8

2.4

10.44

7.82

ug/l

0.60

263

1809

(3035933) Granulocytes/Leukocytes in Blood

426

2.09

9.22

4.6

3.2

57.46

58.74

0.40

426

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

133

753

1.82

9.21

2.8

3.8

205.36

90.11

u/ml

2.54

127

731

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

442

2.06

9.08

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

11.61

8.57

1.4

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

432

5584

0.72

8.50

2.6

3.4

0.73

0.77

ug/l

0.55

291

3788

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.90

8.42

1.2

1.1

—

(44806118) Parainfluenza type 4 nucleic acid detection

288

2.26

8.40

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

288

2.26

8.40

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

288

2.26

8.40

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

288

2.26

8.40

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

3.26

8.08

1.1

—

(3016879) Cocaine [Presence] in Urine

326

2.15

8.05

6.0

1.8

—

(4146454) Self-monitoring of blood glucose

249

2.32

8.02

3.2

2.5

—

(40768443) Skin Pathology biopsy report

149

915

1.67

7.79

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1751

18527

0.73

7.70

6.8

5.5

3.98

4.50

mmol/l

79.04

1654

17218

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

373

2.05

7.68

1.5

—

(40761536) Microorganisms panel - Urine sediment

229

1563

1.52

7.67

5.5

4.0

—

(3000764) Benzodiazepines [Presence] in Urine

348

2.08

7.56

5.9

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.11

7.54

1.1

—

(40768446) Kidney Pathology biopsy report

3.32

7.52

1.4

1.6

—

(3028300) Cannabinoids [Presence] in Urine

350

2.06

7.45

6.5

1.8

—

(3027008) Opiates [Presence] in Urine

350

2.06

7.45

2.9

1.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1742

18411

0.74

7.17

6.6

5.4

1.23

1.42

mmol/l

69.96

1627

16984

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

193

2.41

7.12

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

193

2.41

7.12

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

193

2.41

7.12

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

101

3.00

7.08

2.3

—

(3027944) Amphetamines [Presence] in Urine

344

2.04

7.04

6.1

1.7

—

(3047189) Immunofixation for 24 hour Urine

113

2.86

6.95

1.1

1.9

—

(3016750) Collection duration of Urine

130

2.72

6.93

2.3

2.0

482.64

490.18

min

0.14

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

6.34

6.93

1.2

1.4

82.44

79.70

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

3.02

6.93

3.5

1.4

21.21

28.31

umol/l

5.19

(3038177) Helicobacter pylori Ab [Presence] in Serum

256

2.18

6.72

1.6

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

6.19

6.46

1.2

1.4

76.63

75.00

—

(3032057) Clostridioides difficile [Presence] in Stool

4.07

6.35

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1797

18847

0.74

6.33

7.5

6.3

2.23

2.60

mmol/l

64.33

1685

17444

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

164

1088

1.55

6.28

2.5

2.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.14

6.17

1.0

1.1

1687.71

1481.56

miu/ml

0.46

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

715

8336

0.79

6.16

2.5

2.0

1.45

1.36

mmol/l

1.62

642

6897

(3041096) Erythrocytes [Presence] in Urine by Automated

642

5362

1.28

6.14

5.2

3.5

0.02

0.18

estimate

0.59

256

1713

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

12.55

6.08

4.7

1.6

310.40

135.50

ug/g

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

105

2.79

6.06

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

105

2.79

6.06

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

105

2.79

6.06

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

2.79

6.06

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

134

2.56

6.04

2.4

2.2

—

(3018291) Platelet Ab [Presence] in Serum

15.05

5.90

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

2.40

5.89

1.4

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

108

2.71

5.76

3.3

3.7

1.14

1.22

0.09

108

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

240

2.11

5.70

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

295

1.99

5.67

1.6

1.2

3.54

5.01

u/ml

0.50

142

(3026361) Erythrocytes [#/volume] in Blood

1937

20041

0.72

5.67

72.4

27.2

4.02

4.49

e12/l

162.96

1892

19546

(3035941) MCH [Entitic mass]

1937

20040

0.72

5.65

72.2

27.1

30.89

30.47

11.71

1919

19806

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

221

2.15

5.65

1.7

1.8

—

(3017704) Immunofixation for Urine

145

2.44

5.63

1.2

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

189

2.25

5.62

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

303

1.97

5.61

1.5

1.2

2.58

3.11

u/ml

0.22

108

(3029937) Albumin [Presence] in Urine by Test strip

696

5922

1.26

5.61

5.7

4.1

0.00

estimate

1.15

277

2003

(3004616) Nuclear Ab [Presence] in Serum

236

2.10

5.55

1.2

—

(3010813) Leukocytes [#/volume] in Blood

1938

20042

0.72

5.53

72.4

27.2

6.56

6.80

e9/l

2.63

1897

19554

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1938

20041

0.72

5.52

74.9

27.8

36.27

40.46

151.72

1920

19799

(3000330) Specific gravity of Urine by Test strip

154

1039

1.52

5.49

5.4

3.5

1.02

ratio

0.21

145

960

(3003129) Base excess in Capillary blood by calculation

278

2.00

5.48

2.6

2.3

-1.17

0.40

mmol/l

1.16

270

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1938

20038

0.72

5.47

72.2

27.1

93.20

91.52

30.15

1920

19806

(3007461) Platelets [#/volume] in Blood

1938

20037

0.72

5.45

72.5

27.2

171.18

243.61

e9/l

264.76

1900

19617

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.35

5.44

1.4

0.38

0.31

mmol/l

—

(3000963) Hemoglobin [Mass/volume] in Blood

1939

20043

0.72

5.40

73.2

27.4

120.81

135.73

g/l

197.44

1924

19810

(3039443) Prostate specific Ag panel - Serum or Plasma

516

0.34

5.32

1.3

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

11.29

5.29

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

456

1.76

5.25

1.3

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

144

2.38

5.23

1.4

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

120

2.52

5.21

1.2

126.37

139.91

nmol/l

1.00

120

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

510

1.71

5.21

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

189

2.19

5.20

1.8

2.2

708.75

1202.49

e6/l

4.91

167

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

139

2.40

5.14

1.5

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

514

1.70

5.07

1.2

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

8.37

5.06

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

517

1.69

4.97

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1932

18545

1.35

4.89

48.8

17.9

22.81

26.41

mg/l

8.85

1877

15490

(3039000) Anion gap in Blood by calculation

490

1.70

4.85

10.6

7.9

12.47

11.38

mmol/l

1.36

436

(3018572) Chloride [Moles/volume] in Blood

490

1.70

4.85

10.6

7.9

104.07

105.46

mmol/l

1.44

436

(3026480) Teichoate Ab [Titer] in Serum

6.50

4.77

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.59

4.76

1.8

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

197

2.10

4.72

1.1

98.20

34.20

u/ml

—

(4268621) Lupus anticoagulant assay

211

2.06

4.69

2.6

2.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

239

1.99

4.65

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

3.22

4.61

3.5

8.8

48.10

73.41

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

5.24

4.45

1.0

1.1

—

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.24

4.45

1.0

1.1

—

mmol/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

149

2.23

4.44

1.2

—

(3045424) Erythrocytes [Presence] in Urine

147

1028

1.46

4.44

2.6

2.2

0.00

0.86

estimate

0.51

297

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.40

4.43

2.0

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

607

0.45

4.36

1.2

1.7

—

(3028433) Virus identified in Specimen by Culture

2.90

4.33

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

253

1.92

4.31

3.8

3.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1107

10072

1.20

4.29

3.0

2.5

—

(3014271) Vancomycin [Susceptibility]

108

2.42

4.22

4.2

2.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

460

0.39

4.22

1.2

1.48

1.50

g/l

0.12

460

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.14

4.20

12.2

11.9

4.61

5.35

mmol/l

0.80

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

115

2.36

4.16

3.4

3.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

174

1272

1.40

4.14

1.1

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

168

2.10

4.08

1.7

2.0

1.24

1.38

u/field

0.12

(21494814) CD8 cells/Lymphocytes in Specimen

2.64

4.06

2.0

2.1

25.86

31.66

1.11

(3029634) Reagin Ab [Titer] in Serum by VDRL

259

1.87

4.04

1.9

2.0

—

10.00

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

6.45

3.98

1.1

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

232

1.91

3.98

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

607

1.56

3.93

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.96

3.79

2.1

2.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.70

3.79

1.1

2.1

1.57

1.19

mmol/l

—

(3042517) Benzodiazepines panel - Urine

8.77

3.77

4.0

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

439

1.64

3.77

1.5

12.77

8.49

u/l

0.99

348

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.65

3.73

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

3.84

3.69

1.8

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.02

3.68

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

290

1.78

3.67

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.78

3.55

1.8

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.78

3.55

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.46

3.55

1.2

238.00

205.10

iu/ml

0.17

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

10.02

3.50

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

10.02

3.50

1.0

0.08

—

(4195642) Thrombophilia screening test

265

1.79

3.49

1.4

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

2.18

3.38

1.2

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

246

1.80

3.37

1.4

1.6

74.92

61.76

1.36

155

(3045414) Leukocytes [Presence] in Urine

249

1986

1.29

3.33

2.6

2.1

0.00

0.01

estimate

0.78

389

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

108

2.24

3.32

1.4

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

270

1.76

3.30

2.1

1.4

—

(3022689) Creatine [Moles/volume] in Urine

2.68

3.22

2.1

1.5

8.80

8.58

mmol/l

0.07

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

858

7773

1.17

3.18

5.8

4.0

0.01

0.09

estimate

0.82

272

1821

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

131

2.07

3.12

2.6

34.75

39.03

0.51

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

173

1.92

3.10

1.4

1.8

9299.59

2878.44

u/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

848

9293

0.86

3.06

4.4

5.7

1.77

3.39

ug/l

2.63

747

8428

(40768800) Prostate Pathology biopsy report

634

0.56

3.06

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

167

2156

0.76

3.04

2.2

2.4

13.22

13.52

nmol/l

0.16

148

1932

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.27

3.03

1.4

1.7

36.85

39.75

g/l

1.52

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.85

3.02

1.0

1.1

20.37

22.36

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.85

3.02

1.0

1.1

36.04

37.84

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.85

3.02

1.0

1.1

8.46

8.79

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

278

1.71

3.00

1.3

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

219

1.79

2.98

1.3

1.2

88.51

95.69

0.83

208

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

10.02

2.98

1.0

—

mmol/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.64

2.96

1.3

1.2

13.35

9.25

pmol/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

114

2.12

2.94

1.3

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

184

1.86

2.92

1.4

1.5

18.58

27.13

0.63

113

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.72

2.92

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

128

2.04

2.91

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.10

2.88

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

207

1.80

2.87

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

129

2.03

2.86

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

186

1.84

2.83

5.1

3.0

64.01

33.43

mg/l

0.45

146

(3004716) Salmonella sp identified in Stool by Organism specific culture

103

738

1.42

2.83

1.3

—

(3049717) Cytology report of Urine Cyto stain

130

969

1.36

2.83

2.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.65

2.79

7.7

6.7

6.68

5.43

kpa

0.83

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

181

1.84

2.74

1.3

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1937

19826

0.80

2.68

62.1

23.8

94.58

82.16

umol/l

18.95

1922

19606

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.29

2.67

2.2

2.1

—

(3025130) Human papilloma virus identified in Specimen

133

1.97

2.65

2.3

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

113

2.05

2.61

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1711

17702

0.85

2.58

5.8

4.6

1.40

1.31

mmol/l

5.27

1595

16174

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.39

2.47

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1778

18321

0.84

2.45

7.1

5.6

6.90

6.07

mmol/l

52.52

1674

16711

(3010838) Calcium [Moles/time] in 24 hour Urine

343

1.56

2.44

1.6

2.1

4.58

4.90

mmol/24h

0.22

302

(3034426) Prothrombin time (PT)

2.35

2.39

1.7

1.3

29.07

29.28

0.07

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.65

2.36

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.65

2.36

1.3

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.26

2.34

1.2

33.20

38.80

g/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

155

1.82

2.30

2.3

1.1

81.46

107.03

pmol/l

2.15

155

(3051101) Glucose [Moles/volume] in Cord blood

2.95

2.28

14.2

6.1

9.71

8.62

mmol/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.95

2.28

1.1

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.90

2.25

1.3

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

121

1.91

2.21

2.1

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

419

1.47

2.16

4.6

3.5

27.42

27.88

mg/l

0.03

285

(3023419) Bacteria identified in Sputum by Culture

338

1.52

2.15

4.0

2.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.21

2.11

1.1

—

14.56

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

567

1.39

2.05

1.4

1.6

17981.09

14671.22

e6/l

0.25

389

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.01

2.04

2.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.01

2.04

3.5

4.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1486

14251

1.13

2.00

4.5

4.2

14.76

14.95

pmol/l

2.02

1373

12967

(3014891) Appearance of Pleural fluid

2.82

2.00

2.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.09

1.96

1.3

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.09

1.96

2.4

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.09

1.96

2.4

2.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.34

1.96

2.4

3.3

0.80

0.60

ug/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.55

1.94

8.8

3.5

105.60

104.55

g/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.76

1.93

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.40

1.85

21.0

1.8

—

(40765096) Chromosome analysis panel by Banding

1.98

1.85

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

4.17

1.82

1.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

101

1.89

1.80

1.3

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.27

1.80

1.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

106

826

1.30

1.80

1.7

1.5

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1575

15208

1.13

1.75

61.2

22.2

15.37

13.74

189.12

1568

14990

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.98

1.74

1.1

1.0

—

(1002224) Polysomnography panel

822

0.72

1.72

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.85

1.71

1.4

3.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

113

1.78

1.60

9.9

6.9

163.38

48.86

u/ml

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

136

1.70

1.59

1.6

1.5

101.43

87.39

umol/l

0.94

136

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.01

1.58

1.0

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.01

1.58

1.2

1.3

1.11

1.39

umol/l

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

199

1.57

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

588

1.32

1.55

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.11

1.55

1.2

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.93

1.54

1.3

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

130

1.70

1.53

1.4

2.3

321.94

609.07

e6/l

1.67

107

(3010144) Erythrocytes [#/volume] in Synovial fluid

210

1.53

1.48

1.1

1.3

26814.33

86087.57

e6/l

0.97

140

(4094501) Cardiovascular stress test using bicycle ergometer

639

0.71

1.48

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

1.75

1.46

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1929

19615

0.86

1.44

34.4

13.0

38.48

26.62

u/l

23.71

1910

19028

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.13

1.44

1.0

—

(44806071) Cardiolipin IgM antibody measurement

2.73

1.43

1.5

1.0

—

(3008898) HLA-B27 [Presence]

530

0.69

1.42

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.86

1.40

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.18

1.40

1.6

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.90

1.39

4.9

2.5

4.53

4.85

kpa

0.64

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.90

1.39

4.9

2.5

10.17

10.05

kpa

0.06

(3020393) Adenovirus Ag [Presence] in Stool

2.95

1.36

1.4

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.83

1.35

1.2

1.4

125.53

178.64

mmol/24h

1.35

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

153

1804

0.84

1.34

1.5

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

137

1144

1.21

1.34

1.3

255.87

234.66

u/ml

0.16

132

1061

(40768793) Breast Pathology biopsy report

370

0.64

1.34

1.5

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.50

1.30

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

126

1048

1.21

1.29

2.9

3.5

3.84

4.44

pmol/l

9.34

115

930

(3004451) EKG impression Narrative

161

1.56

1.28

1.4

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.78

1.28

1.0

1.3

—

(40757373) Influenza virus identified in Isolate

2.09

1.27

1.3

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.86

1.24

1.2

1.3

146.60

118.80

nmol/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.00

1.23

1.3

1.2

1.16

1.18

mmol/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.00

1.23

1.2

1.5

—

159.14

—

(3024263) Appearance of Synovial fluid

108

1.67

1.22

1.6

1.5

—

(3013637) Mi-2 Ab [Presence] in Serum

1.84

1.19

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.84

1.19

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.84

1.19

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.84

1.19

1.2

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

1.16

0.0

1.1

—

53.25

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.06

1.15

8.0

7.9

10.56

10.41

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.06

1.15

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

1.15

1.8

1.4

10.40

16.30

u/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.34

1.12

1.0

1.2

—

(3022621) pH of Urine by Test strip

176

1531

1.16

1.12

3.1

2.7

5.92

6.05

1.41

143

1065

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.97

1.11

1.8

1.0

445.00

258.00

pmol/l

—

(3028717) Thiamine [Mass/volume] in Blood

2.26

1.10

1.1

1.3

57.43

67.48

ug/l

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.38

1.09

1.0

1.8

0.07

0.16

nmol/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

269

1.38

1.08

3.0

2.4

16.69

20.46

mg/l

0.45

104

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1163

0.83

1.06

1.2

1.4

—

(3012565) Volume of 24 hour Urine

105

1.62

1.06

2.4

3.0

2112.35

1840.79

0.36

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.28

1.03

2.6

2.9

0.60

0.41

u/field

—

(3033099) Centromere Ab [Titer] in Serum

2.06

1.03

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.84

1.02

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.62

1.00

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

207

1.41

0.96

1.0

1.1

6.93

2.08

eliau/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

108

1.58

0.96

1.5

1.6

—

(3006270) Folate [Moles/volume] in Blood

149

1.48

0.95

1.4

1.2

273.67

358.16

nmol/l

1.06

128

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.91

0.88

1.4

1.1

—

(44806420) Estimation of glomerular filtration rate

177

1.42

0.88

2.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

487

1.24

0.85

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.74

0.82

1.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.2

—

2.00

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.67

0.78

1.6

1.4

109.63

107.67

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

359

3340

1.09

0.78

1.3

43.96

33.88

iu/ml

0.71

123

1039

(1617658) Protocol used for examination of sentinel lymph nodes

125

0.56

0.77

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

969

0.85

0.74

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.75

0.71

1.3

1.1

—

0.74

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

239

1.30

0.69

1.3

0.19

nmol/l

0.02

197

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1793

18170

0.93

0.68

47.1

17.7

73.77

77.36

ml/min/173m2

7.78

1734

16991

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.53

0.68

6.6

2.3

1.44

1.18

ug/l

—

(3002619) Bacteria identified in Specimen by Culture

1.63

0.66

2.0

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.79

0.66

1.0

2.0

13.80

16.96

umol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

0.64

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

129

1.40

0.63

2.7

2.1

92.20

132.02

ng/l

1.16

129

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

233

2520

0.92

0.62

16.0

7.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

178

1623

1.11

0.62

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1744

17198

1.07

0.62

5.9

5.2

2.28

1.97

mu/l

11.58

1642

15727

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.54

0.59

1.0

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

377

0.79

0.59

1.6

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.51

0.58

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.54

0.55

1.4

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.50

0.54

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.48

0.53

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

823

0.87

0.53

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.41

0.51

1.0

1.1

—

(4015189) Microbial culture of sputum

1.41

0.51

1.8

2.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

303

0.79

0.51

1.3

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.46

0.50

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

156

0.70

0.49

4.4

5.9

20.16

41.49

u/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.49

0.49

1.2

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.56

0.49

1.4

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.52

0.48

1.0

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.47

0.47

1.0

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1486

15077

0.96

0.45

61.3

23.5

330.57

332.42

g/l

9.27

1477

14998

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

114

1039

1.10

0.44

1.1

1.2

112.34

139.86

u/ml

0.30

370

(3023323) Follitropin [Units/volume] in Serum or Plasma

424

1.16

0.43

1.6

1.4

29.94

28.22

iu/l

0.13

356

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.41

0.0

8.1

—

8.53

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.41

0.0

4.1

—

45.60

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

888

0.90

0.41

1.6

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.47

0.40

3.2

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

177

1.25

0.40

1.0

1.1

0.68

2.56

u/ml

1.91

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.33

0.40

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.34

0.38

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

478

4621

1.04

0.35

5.9

4.2

1.02

kg/l

0.28

349

3111

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

125

0.72

0.35

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

287

0.83

0.34

3.5

5.2

347.53

348.22

umol/l

0.01

260

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.37

0.34

2.0

2.1

17.68

129.17

ug/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

520

1.12

0.33

1.4

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

188

0.80

0.33

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.69

0.33

1.0

—

(4211845) Urine protein measurement

0.67

0.33

3.3

3.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

111

1194

0.93

0.32

1.3

55.71

60.38

au/ml

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.35

0.31

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

333

1.14

0.31

1.4

1.8

21.29

27.16

ug/l

0.33

327

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

110

0.73

0.28

1.0

1.2

—

(4034850) Laboratory test

622

1.10

0.28

19.2

10.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

123

1306

0.94

0.27

2.6

2.5

27.43

20.30

au/ml

—

109

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.22

0.25

1.9

1.5

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.19

0.21

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.4

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

0.18

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

83.90

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

484.75

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.60

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

40.38

—

(44813793) Dust mix specific IgE antibody measurement

102

0.78

0.21

1.1

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

105

0.76

0.21

1.1

—

18.97

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

6.66

—

(3005570) Glucose [Moles/volume] in Urine

203

1.13

0.19

2.0

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

322

3139

1.03

0.18

1.3

14.55

12.28

u/ml

0.19

115

1176

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

272

1.10

0.17

1.3

0.78

7.14

nmol/l

0.48

262

(3016018) Differential panel - Cerebral spinal fluid

235

1.11

0.15

1.2

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

150

0.87

0.14

1.9

2.2

14.78

3.24

ug/l

0.57

141

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

227

1.10

0.14

1.4

1.3

—

nmol/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

107

0.84

0.13

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

242

2367

1.03

0.12

1.4

—

(3023410) Appearance of Cerebral spinal fluid

218

0.92

0.10

1.4

1.5

—

(4024509) Urine culture

960

1.03

0.09

2.1

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

233

1.07

0.09

1.2

1.3

—

(3000285) Sodium [Moles/volume] in Blood

1.11

0.09

1.2

1.1

136.67

139.38

mmol/l

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.12

0.07

1.4

1.6

9.46

8.67

ug/l

0.14

(3023103) Potassium [Moles/volume] in Serum or Plasma

1937

19403

0.99

0.06

61.0

21.9

4.03

4.00

mmol/l

3.96

1919

19020

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

213

0.94

0.06

1.1

1.3

10.35

7.49

mmol/l

1.74

185

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

151

0.93

0.05

1.0

1.1

1.08

0.21

u/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

150

1.07

0.04

1.4

1.3

2.21

0.98

u/ml

—

(3032773) Endomysium IgG Ab [Titer] in Serum

170

0.94

0.04

1.1

—

titre

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1804

18065

0.99

0.04

12.1

7.0

43.86

40.02

mmol/mol

30.89

1728

16836

(3010726) Horse dander IgE Ab [Units/volume] in Serum

210

0.95

0.03

1.1

0.41

1.52

u/ml

1.42

111

(3008401) Mugwort IgE Ab [Units/volume] in Serum

220

0.95

0.03

1.0

1.1

1.23

1.54

u/ml

—

100

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

320

0.97

0.03

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

351

1.03

0.02

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

268

0.97

0.02

1.0

1.1

6.29

2.09

u/ml

0.45

154

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

292

1.03

0.02

2.0

1.9

—

(40768795) Lymph node Pathology biopsy report

203

1.03

0.01

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

166

0.96

0.00

1.1

0.79

4.09

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

256

0.98

0.00

1.3

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

225

1.02

0.00

1.0

1.1

4.57

4.26

u/ml

0.04

119

(3003740) Influenza virus B Ag [Presence] in Specimen

255

0.98

0.00

1.3

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

461

1.00

0.00

1.6

1.5

354.05

729.35

e6/l

0.58

355

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

464

0.99

0.00

1.7

2.0

3.38

16.90

iu/l

0.53

181

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

255

2554

1.00

0.00

5.5

5.2

31.11

32.39

1.06

207

1645

(3019550) Sodium [Moles/volume] in Serum or Plasma

1937

19366

1.00

0.00

60.8

21.6

138.01

139.72

mmol/l

96.64

1919

19018

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

457

1.01

0.00

1.5

1.4

236.88

45.25

e6/l

0.39

335

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.67

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.1

—

26.66

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.88

0.00

1.0

1.2

14.83

9.74

mm/h

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.9

—

1.31

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.98

-0.00

1.2

1.7

74.33

646.16

nmol/24h

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.2

—

383.40

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

428.20

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

1.96

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.93

-0.00

1.3

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint CHIRHEP_NAS and mortality.

Females

Parameter	HR [95% CI]	p-value
CHIRHEP_NAS	8.169 [6.82, 9.79]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.963

During the follow-up period (1.1.1998 — 31.12.2019), 2224 out of 3896 females with CHIRHEP_NAS died.

Males

Parameter	HR [95% CI]	p-value
CHIRHEP_NAS	9.397 [7.67, 11.51]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 3499 out of 5661 males with CHIRHEP_NAS died.

Mortality risk

Mortality risk for people of age

years, who have CHIRHEP_NAS.

N-year risk	Females	Males
1	1.008%	1.497%
5	5.56%	9.387%
10	12.789%	23.294%
15	24.546%	38.804%
20	39.066%	57.792%

Relationships between endpoints

↥

Index endpoint: CHIRHEP_NAS – Cirrhosis of liver, NAS

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cirrhosis of liver, NAS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints